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ABSTRACT 
Big data analytics in healthcare context is often studied from a technical point of view. In the 
field of strategic management, researchers have indicated a research gap in how big data 
analytics create business value. This study examines how big data and advanced analytics 
generate potential benefits and business value for the healthcare service provider, and value 
for the individual patients and population health. In addition, the effects of advanced analytics 
to the value co-creation practices and actors in healthcare ecosystem are studied. The 
theoretical framework used for the purpose is the big data analytics-enabled transformation 
model which is adapted to answer the research questions. The study is conducted as a single 
case study. The studied case is the Health Benefit Analysis (HBA) tool. The empirical data 
is collected in eight semi-structured interviews with participants of the tool development 
project.  
 
Using the HBA tool reveals several paths-to-value chains. The most evident path shows how 
using advanced analytics affects the personalized care practice by enabling a more interactive 
service process between the health professionals and patients. It denotes a business scope 
redefinition as patients are now being interpreted as essential actors in the value co-creation 
of their own health outcomes. The benefits that arise from the advanced analytics are of 
several dimensions; operational, managerial, strategic, and organizational. Using the HBA 
tool generates strategic business value for the healthcare service provider as a differentiator 
that contributes to gaining competitive advantage compared to other service providers not 
using this innovation. Value emerges for the individual patient as improved patient 
experience and better health outcomes. Population health gains most value from the reduced 
health inequalities.  
 
The evolving value co-creation practices set requirements for the healthcare ecosystem actors 
as they need to conform to new practices with patients and other professionals from other 
sectors and levels of the ecosystem. The healthcare work and service culture need to develop 
and adapt to new tools, related processes, and a more diversified professional base, including 
health analysts and other new professionals. To conclude, it can be claimed that advanced 
analytics of healthcare big data contributes to the shift to value-based healthcare. 
 
KEYWORDS: value co-creation, big data analytics, value-based healthcare, health benefit  
analysis, healthcare ecosystem.  
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1. INTRODUCTION 
 
Digitalization has rapidly become reality for many industries by disrupting old business 
models. New and enhanced value co-creation practices yield possibilities to offer increased 
value and various potential benefits for the business owners, individual customers, and entire 
customer segments. Digital transformation has also had its effect and changed the way of 
thinking and way of working in the healthcare industry. This change is still ongoing, and the 
development of digital healthcare services, related medical products and equipment, as well 
as the electronic information systems in the field, continue to evolve in the future.  
 
 
1.1. Background of the study 
 
According to Barlow (2016: 3, 13), the medical knowledge base is growing exponentially, 
since more data is collected about the patients and new medical information is published 
every day, which no single human being can keep up with, leading to a situation where 
doctors and other care staff need help to succeed with this highly complex field of life 
sciences. According to Obermeyer & Lee (2017: 1209), every patient is a “big data” 
challenge, as medical knowledge is expanding rapidly, and patients are older with more 
coexisting illnesses and medications. Further, Barlow (2016: 1 – 3) claims that the traditional 
labor-intensive healthcare transforms into more knowledge-driven and data-intensive 
practice where the newer healthcare delivery models depend on user-friendly, real-time big 
data analytics, artificial intelligence (AI) and machine learning (ML) tools, and that millions 
of individual patients may benefit from the improved capabilities on diagnosis and 
treatments. Also, according to Rose and Burgin (2014: 11), real-time big data analytics has 
the potential to enable well-timed interventions to get customers, i.e. patients the right care, 
at the right time, and in the right venue. This, in turn narrows the potential gaps in healthcare 
delivery, and in that means, generates potential savings by improving the operating 
conditions, as well as competitiveness of the healthcare service providers. The improved 
capabilities can become an asset on population level as well, for example with disease 
management and epidemics tracking, such as hotspots of Malaria, or by providing 
estimations of influenza activity as Google Flu Trends does (Sahay 2016: 420, 426; 
Raghupathi & Raghupathi 2014: 8). Moreover, it can help with ensuring the needed proactive 
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care delivery and interventions for specific groups of patients suffering from similar health 
problems, e.g. heart failure or hypertension (Kunnamo 2017).    
 
To become one of the game changers and to contribute to the discussion, healthcare service 
providers should invest in investigating the value and potential benefits of big data and 
advanced analytics, for example how data analytics could enhance the offered healthcare 
services and ensure that these services optimally meet the patients’ needs and improve their 
health condition. From a business development point of view, it should be evaluated how the 
use of advanced analytics can create value for the actors in the healthcare ecosystem, as well 
as for the end customers, i.e. the specific populations and individual patients. 
 
Regarding the development of information technology in healthcare (E-Health) in the 
European Union, scholars have indicated some inequalities between the member states, as 
many of them, usually the richest ones, have been able to invest more in the development, 
while some countries have not. Therefore, the European Council urged in 2013 for the 
reduction of the digital gap in healthcare amongst the member states. (Quaglio, Dario, 
Stafylas, Tiik, McCormack, Zilgalvis, D’Angelantonio, Karapiperis, Saccavini, Kaili, 
Bertinato, Bowis, Currie & Hoerbst 2016: 314). The European Union (2016) also carried out 
a systematic literature review and consultation of experts to identify examples of the use and 
value of big data analytics in the practice of public healthcare and telemedicine, and to 
identify whether there is a need for policy recommendations to develop and support the use 
of big data in public health. This review also confirms that the increasing availability of data 
and technical progress combined with limited financial resources, stakeholders in public 
health as well as the scientific community are open to the opportunities offered by big data 
applications not only for the health of the individual but also for the health of the whole 
population. Moreover, the review indicates that the use of big data might improve also the 
performance and outcome of healthcare systems. (European Union 2016: 22, 25.)  
 
The most important lesson the European Union (2016: 55) learned in its review was that 
raising awareness of the added value of big data in health is needed quite urgently by 
stimulating a continuous open dialogue with all stakeholders and patient groups. 
Consequently, the public discussion around the major potential benefits and challenges of 
big data in health is in full flow and will continue in the coming years.  
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In order to achieve any potential benefits and expected value from advanced and big data 
analytics, there are, however, many challenges on the way. These issues need to be studied 
and answered to, which makes the effects of data analytics to value co-creation practices in 
the field of healthcare an interesting research topic. Moreover, according to McKinsey & 
Company reports (Manyika, Chui, Bughin, Dobbs, Bisson & Marrs 2013: 11) big data 
applied with disruptive technologies like Internet of Things, cloud, next generation genomics, 
and advanced robotics, are expected to increase significantly and become a trillion-dollar 
business by 2025. It is also estimated to reduce healthcare spend in US of $300 billion to 
$450 billion (Groves, Kayyali, Knott, Van Kuiken 2013: 8 – 9). Big data is of great 
significance in optimizing the costs of public and private health systems, and it also promotes 
healthy lifestyles and activities, helping people to avoid chronic diseases (Chen, Ma, Song, 
Lai & Hu 2016: 830), so it definitely pays off to resolve as many challenges as possible in 
the years to come.  
 
 
1.2. Research gap 
 
Studies have indicated that there are challenges with matching the capacity of healthcare 
units with the need of care of patients, which requires to develop systems that increases the 
accessibility for care and better match the supply and demand (Nordgren 2011: 304). Such 
systems can be considered as platforms for value co-creation opportunities for healthcare 
service providers and healthcare consumers, referred to as patients (Andrews, Sahama & 
Gajanayke 2014: 375). Moreover, the study of Andrews et al. (2014: 378 – 379) indicates 
some promising effects caused and value created by using digital resources in healthcare 
service setting. Therefore, there is demand for additional studies regarding value co-creation 
models of digital healthcare services. Bardhan and Thouin (2013: 447) also indicate the 
importance of examining the information technology enabled capabilities and the impact of 
these capabilities on the process and quality outcomes in order to explain how benefits can 
be derived from adapting information technology in healthcare. 
 
To gain further understanding of the nature and scope of value co-creation, Lusch, Vargo & 
Gustafsson (2016: 2060 – 2961) conclude in their research on transdisciplinary service 
ecosystems, that more opportunities to study service ecosystems based on digital platforms, 
including for example computer and information sciences, should be considered. This makes 
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sense, since such service ecosystems involve in value co-creation not only human actors, but 
also organizational and digital artifacts. According to Storbacka, Brodie, Böhmann, Maglio 
& Nenonen (2016: 3008), actor engagement as microfoundation for value co-creation has 
become a major research stream in strategic management, as it is empirically more 
observable than value co-creation itself. Storbacka et al. (2016: 3013) indicate several 
research gaps related to actor engagement, one particularly concerning the role of machine 
actors, for example advanced algorithms which are predicted to play a much bigger role in 
service ecosystems in the future.  
 
According to Demirkan, Bess, Spohrer, Rayes, Allen & Moghaddam (2015: 734) big data is 
a business priority that has the potential to change the competitive landscape of today’s 
globally integrated economy by providing innovative solutions and new ways to transform 
processes, organizations, entire industries, and even society. However, the research of big 
data and big data analytics have so far concentrated mostly on the technical side, whereas the 
business value, as well as managerial and strategic views especially in the field of healthcare 
has not yet been sufficiently explored (Wang, Kung & Byrd 2016: 1; Sivarajah, Kamal, Irani 
& Weerakkody 2017: 279 – 280; Wang & Hajli 2017: 295). Uncovering the potential value 
and benefits for various stakeholders, governments need to invest time, resources, visioning, 
and planning on how to successfully implement big data technologies (Archenaa & Mary 
Anita 2015: 313) and in future research on how recent advancements on information 
technology and big data analytics systems can be effectively exploited in healthcare services 
(Sakr & Elgammal 2016: 57). 
 
 
1.3. Objectives and research questions  
 
Value co-creation practices have a major role in how value is created. Since the digitalization 
has its effect in value co-creation practices and involved actors, and because the research of 
the value of advanced data analytics and big data analytics in healthcare industry is lagging 
compared to other industries, it is worth to conduct a research on this topic. Thus, the 
objective of this study is to discover how using big data and advanced analytics create 
potential benefits for healthcare service providers and consumers, i.e. the specific populations 
and individual patients, and how it affects in value co-creation practices in the healthcare 
ecosystem.  
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These research objectives are studied by answering to the following research questions: 
 
RQ 1.  How does big data and advanced analytics generate potential benefits and value for 
healthcare service providers, individual patients, and population health?  
 
RQ 2. How does big data and advanced analytics affect the value co-creation practices and 
actors in a healthcare ecosystem? 
 
Finding out how big data and advanced analytics create value and benefits for various 
stakeholders, contributes the healthcare service organizers and providers to indicate and 
analyze potential care gaps and plan how to narrow the deficits by optimizing healthcare 
services timely and cost-effectively for those patients who benefit most from them.  
 
 
Figure 1. Three perspectives to potential benefits and value. 
 
Specifically, the study is concentrated on the potential benefits and value that arise from 
introducing advanced analytics of healthcare big data as an actor in the value co-creation 
practices. The value is viewed from three perspectives; the healthcare service provider’s, 
population health’s and individual patient’s (Figure 1). The study discusses also how 
advanced analytics affects the value co-creation practices and respective actors in the 
healthcare ecosystem. It is also possible to identify new types of actors emerging in the 
healthcare ecosystem due to the use of big data and advanced analytics. This may provide 
insights for management in how to develop its resources and needed competencies.  
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The theoretical contribution of this study fills in the stated gap in research of the impact of 
big data analytics in the field of healthcare, using the concept of value co-creation from the 
discipline of strategic management. Also, the theoretical framework used for analyzing the 
paths-to-value chains and specific benefit dimensions, which is primarily intended for 
revealing the business value of big data analytics solely from the healthcare service 
organizer's or provider's perspective, will be extended so that it also sheds light on the 
potential benefits for individual patients and population health. The managerial implications 
include the affected value co-creation practices which need to be considered when planning 
to introduce advanced analytics or big data analytics in healthcare context. Moreover, the 
discovered potential benefits for the stated stakeholders are presented, and a summary of 
identified challenges and opportunities are discussed.   
 
 
1.4. Thesis structure 
 
The thesis first introduces the background to the topic and discusses the potential areas of 
research interests and needs in the field, explains research objectives, and presents the 
research questions. The second chapter introduces the context of the study that is value-based 
healthcare through health benefit analysis, as well as discusses the characteristics of 
individual and population health management. The literature review covers the concepts and 
principles of value, value co-creation, service systems, as well all as characteristics of typical 
co-creation practices and actors in a healthcare ecosystem. The theoretical part continues 
with discussing big data and big data analytics. Last, the framework for analyzing the value 
and potential benefits of big data analytics is introduced and extended to cover not only the 
business value, but also the value for population health and individual patients. 
 
The theoretical part is followed by the methodology, which introduces the used research 
method and explains the background and reasons why that method was selected. Also, the 
collection, handling and analyzing methods of the empirical data is explained in detail. 
Finally, in the results chapter the case is introduced, and the results of the analyzed empirical 
data is reported. The results are compared to the theory, which is the base for conclusions. 
The conclusions consist of key findings, theoretical and managerial implications, as well as 
ideas for future research. 
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2. DATA-DRIVEN VALUE CO-CREATION IN HEALTHCARE 
 
This chapter first introduces the context of the study, i.e. information technology (IT) enabled 
value-based healthcare through health benefit and care gap analyses. It also describes the 
purpose and target groups of the analyses, as well as discusses briefly the users, that primarily 
are professionals representing various healthcare service providers.  
 
Further, it introduces through literature review the characteristics of value and value co-
creation, related service logics, as well as discusses how co-creation practices and actors are 
perceived in healthcare ecosystems, and raises the potential impact of digital actors, e.g. data 
analytics and algorithms as value co-creators. The chapter continues with introducing the 
concept of big data and advanced analytics, especially in the healthcare context. Finally, the 
theoretical framework for studying the effects and potential benefits through advanced data 
analytics, on which the health benefit analysis is based, is presented. The framework used for 
the purpose is the 'big data analytics-enabled transformation model', which includes selected 
organizational IT-enabled practices treated and examined in this study as value co-creation 
practices. The model includes also specific benefit dimensions, which are explored not only 
from the business value point of view, but also to find out what kind of value propositions it 
creates for individual patients and population health management. Therefore, specifically for 
this study, an applied version of the big data analytics-enabled model is developed and 
introduced. 
 
 
2.1. Value-based healthcare 
 
Healthcare is often perceived as expensive and inefficient. Moreover, healthcare service 
delivery outcomes are of varied quality. Therefore, there is room for improvement and need 
for changing the focus of how success of healthcare is measured. Instead of monitoring 
healthcare efficiency with the number of patient visits or number of performed tests and 
procedures, the interest should be in the effectiveness of medical and care interventions, for 
example on quicker patient recoveries, fewer readmissions to the hospital, lower infection 
rates, and fewer medical errors. In other words, healthcare should be valued by its outcomes, 
which is referred to as value-based healthcare. The goal of value-based healthcare is to lower 
the healthcare costs and improve the quality and outcomes of healthcare service delivery. 
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(Cosgrove 2013.) Porter & Teisberg (2006: 4 – 5, 155) argue that the primary goal of each 
healthcare provider must be excellence in patient value. They also agree with that value of 
healthcare can only be measured over the care cycle, not by individual procedures, services, 
office visits or tests, and raise a concern about the fact that among doctors there is a lack of 
overall perspective on the care-cycle, and that navigating in the care-cycle is challenging for 
patients. Therefore, they suggest paying attention to current practices and test how they 
contribute to creating value for the patients, instead of focusing on short term costs and 
battling over who pays what. Moreover, Porter & Teisberg (2006: 8) claim that value-based 
competition among healthcare service providers cuts out the inefficiency and quality 
problems that plague healthcare services and motivates the poorly performing service 
providers to improvement.   
 
Porter (2010: 2477 – 2478) has also argued that achieving value for patients should be the 
overarching goal of healthcare delivery. Further, value in healthcare is created by the health 
outcomes which can be evaluated on individual patient or population level. The goal is what 
matters for patients and unites the interest of all actors in the system. Value should also define 
the framework for performance improvement in healthcare delivery.  
 
Shifting the focus to value-based healthcare means that healthcare service providers must 
solve a challenging puzzle, because they are expected to reduce variation in quality and 
produce improved outcomes at lower costs. However, this can be viewed as an opportunity 
for development. For example, value-based care teams can be established, unnecessary 
practice variation can be eliminated by developing evidence-based care paths across diseases, 
comprehensive care coordination can be improved so that patients move seamlessly through 
the system, as well as unnecessary visits in health centers and hospitalizations can be reduced. 
(Cosgrove 2013.) In order to develop more qualified and value-based healthcare services, 
information technology platforms and data-driven solutions play a major role (Cosgrove 
2013; Barlow 2016: 1 – 3). One possibility to improve the value of healthcare for individual 
patients and specific populations, is to perform health benefit analyses in order to target the 
interventions and care for those in need, and for those who would gain most benefit out of 
them.  
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2.1.1. Health benefit analysis and care gap  
 
Health benefit analysis and care gap, are two central concepts to understand when discussing 
the health impact of the outcomes of specific interventions. The health benefit analysis has 
according to Kunnamo & Alper (2017) two phases: determining the care gap and calculating 
the health benefit of filling the gap.  
 
According to Kunnamo & Alper (2017: 2 – 3) The health benefit analysis for an individual 
is a list of net impacts of different interventions. For the patient, a health impact can be 
considered as a benefit or a harm. The net benefit or harm of an intervention is the sum of 
net impact of all its outcomes. Further, “the health benefit is the net benefit of an intervention, 
which is calculated by subtracting the sum of all important harms from the sum of all 
important benefits”. On individual level, health benefit analysis acts as a tool for making a 
care plan and shared decisions between the patient and the doctor when making choices 
between alternative interventions (Kunnamo & Alper 2017: 3). The freedom of choice 
regarding the interventions creates value for the patient and means that the doctor and patient 
are practicing shared decision-making which differs from the traditional situation where 
doctor is responsible for the decision-making and risk-bearing when deciding which 
interventions are most beneficial and impactful for the patient’s health. (McGuire, Henderson 
& Mooney 1988: 39, 46, 48; Jung & Padman 2015: 302). However, it is often claimed that 
patient is deemed to be in an asymmetric relation to healthcare providers and thus incapable 
of making purposeful choices based on sufficient knowledge, as well as that in case the doctor 
fails to give patients information about alternative interventions, the patients possibility to 
choose is strongly impaired (Nordgren 2011: 309). In this respect, the health benefit analysis 
seems to be promising. 
 
On the population level, the health benefit analysis helps the healthcare service providers to 
allocate resources for medical services and interventions that provide the largest health 
benefit for the population in the most cost-effective manner. Thus, the health benefit analysis 
for a population is a care gap analysis listing how many people would benefit from each 
intervention complemented by numbers that indicate the average health impact of each 
intervention. (Kunnamo & Alper 2017: 3 – 4.) Such innovative use of advanced analytics is 
comparable to other innovative internet technologies which can be valuable for underserved 
populations as with this technology care providers can reach patients who otherwise would 
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not have access to healthcare service they could benefit from (Jung & Padman 2015: 299 – 
300).  Practical examples of the described health benefit analyses (Kunnamo & Alper 2017) 
are presented in Appendix 1. 
 
The concept of care gap in healthcare context seems often to be related to a specific medical 
condition or population, such as patients with heart disease, children, women, the elderly, or 
an ethnic group. A general definition of a care gap, provided by The Free Medical Dictionary 
(2017), according to which health care gap is “a disparity between healthcare needs, and the 
healthcare services, especially as it applies to the medically indigent”. This definition 
supports the concept of health and well-being gap which Sitra (2017) describes being the care 
gap between the needs of an individual patient and the healthcare services offered or available 
for the individual patient or a group or a population of similar patients. The gaps can also be 
caused by patient’s hidden needs which currently can be found only randomly when the 
patient is visiting a doctor for another reason. Care gap analysis, as well as the plans how to 
implement it, are also discussed by Lehto and Neittaanmäki (2017: 19 – 21) in their report 
regarding the Finnish health data environment. However, they do not provide any 
comprehensive definition to the care gap or care gap analysis concepts, therefore the concepts 
and definitions provided by Kunnamo & Alper (2017) and Sitra (2016) are applied 
accordingly in this study. 
 
2.1.2. Individual patient’s and population health management 
 
An individual person’s health and wellbeing depends on many factors, such as the person’s 
overall health condition, living and health behavior habits. In cases of sudden illness or long-
term illness, the person becomes a patient, or a consumer of healthcare services run by public 
or private healthcare providers. The individual patient is treated with interventions ordered 
or recommended by doctors and healthcare professionals. The recommended interventions 
and treatments are based on the medical professionals’ expertise and assessments on what 
would be the most beneficial for the patient’s health. In addition, to get well, or improve their 
health condition, the patients also themselves have to take responsibility for their care with 
following the recommendations and possibly make some changes in their lifestyle. 
According to Batalden, Batalden, Margolis, Seid, Armstrong, Opipari-Arrigan & Hartung 
(2016: 509), in such situation health outcomes, in good and bad, are co-produced between 
doctor and patient, and emphasize the importance of effective communication so that a shared 
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understanding of the problem and mutually acceptable care plan can be created. This is 
supported also with the empirical evidence on that informed and activated patients may be 
effective in facilitating good health outcomes at lower cost (Batalden et al. 2016: 509). 
 
Porter (2010: 2478) argues, that value for an individual patient is created by providing 
combined efforts over the full cycle of care and that benefits, and outcomes of care depend 
on how successfully the practices and interventions are integrated. However, according to 
Health Level Seven International1 (2013: 6 – 7), care planning and coordination of care 
delivery over time and across multiple settings and disciplines has long challenged the 
healthcare community due to the complexity of chronic conditions, increased number of 
interventions, and care across multiple sites. Therefore, it recommends healthcare service 
providers to use digital and standardized integrated care plans, which cover all conditions 
and treatments of an individual patient. Also, Nordgren (2009: 124) points out the importance 
of care coordination in order to avoid ineffective use of healthcare capacity and staff, 
decreased accessibility and long waiting periods to healthcare, as well as the risk of offering 
inadequate care for an individual patient.  
 
Population health has been defined in literature in different ways, because it is, according to 
Kindig (2007: 139 – 140), a relatively new term and there has not been agreement whether it 
refers to the concept of health or to the field of study of health determinants. Therefore, 
Kindig and Stoddart (2003) and Kindig (2007) have studied the concept thoroughly to be 
able to provide a suggestion for how to determine population health and how to define the 
concepts related closely to it. As a result, they define population health as “the health 
outcomes of a group of individuals, including the distribution of such outcomes within the 
group” (Kindig & Stoddart 2003: 381; Kindig 2007: 143).  
 
Some authors have chosen other viewpoints to define population health, and for example 
Dunn and Hayes (1997: S7) in their turn determine population health as “the health of a 
population as measured by health status indicators and as influenced by social, economic, 
and physical environments, personal health practices, individual capacity and coping skills, 
                                                 
1 Health Level Seven International (HL7, http://www.hl7.org/) is a not-for-profit, ANSI-accredited 
standard developing organization dedicated to providing a comprehensive framework and related 
standards for the exchange, integration, sharing, and retrieval of electronic health information that 
supports clinical practice and the management, delivery, and evaluation of health services. 
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human biology, early childhood development, and health services”. (Kindig 2007: 143 – 
145.) 
 
Population health outcomes are discussed extensively in the literature as well, and for 
example Kindig (2007: 148) provides a definition for the outcomes as “all possible results 
that may stem from exposure to a causal factor from preventive or therapeutic interventions; 
all identified changes in health status arising as a consequence of the handling of a health 
problem”. Further, health outcome measures can be classified for example to mortality rate, 
morbidity, disability, health status, and quality of life.  
 
Evans and Stoddart (1990) define population health outcomes and their distribution in the 
population with specific health determinants such as social environment (e.g. income, 
education occupation), physical environment (e.g. clean air and water, urban design of 
neighborhoods), genetic endowment, individual response (behavior/habits and biology), 
health care (access, quantity and quality of health care services), disease, health and function, 
well-being, and prosperity. (Kindig 2007: 153.)  
 
According to Kindig (2007: 142), population refers to a group of individuals, in contrast to 
the individuals themselves, organized into many different units of analysis, depending on the 
purpose of the research. A population can be for example a geographic region, nation, 
community or a group of employees, disabled persons, or ethnic groups (Kindig & Stoddart 
2003: 381).  
 
To create value and by that means benefit for the whole society, healthcare organizations 
need, as their core responsibility, to improve the health of populations and individual 
patients’ experience of care, but at the same time also reduce the cost per capita of healthcare 
(Kindig & Isham 2014: 7). Triple Aim, framework developed by Institute for Healthcare 
Improvement2, is a contemporary concept striving to fulfill the mentioned three aspects. 
Kindig & Isham (2014: 3) propose, that the Triple Aim framework is complemented by 
developing a specific multisectoral community health business partnership model, which 
they claim to be even better for achieving the goals. 
                                                 
2 The Institute for Healthcare Improvement (IHI, http://www.ihi.org/), an independent not-for-profit 
organization based in Cambridge, Massachusetts, is a leading innovator, convener, partner, and driver 
of results in health and health care improvement worldwide. 
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However, a common challenge for healthcare systems funded through taxation, regardless 
how it is organized, is to decide what services to offer and to whom, within a limited budget 
(Airoldi, Morton, Smith & Bevan 2014: 965). This may cause inequalities among local 
population of a healthcare center, as some patients are offered interventions they need, and 
due to several reasons, some are not. Some patients may be even unnecessarily over-treated. 
To ensure that interventions are delivered in equal manner, and to provide a tool for the local 
health planners in their annual task of allocating fixed budgets to a wide range of types of 
healthcare and improve population health in a specific geographical area, Airoldi et al. (2014: 
965) have developed a model for socio technical allocation of resources (STAR) including a 
value-for-money triangle (Figure 2), which can be used for evaluating the cost-effectiveness 
of interventions and expected benefits, as well as how to improve population health and 
reduce possible inequalities among population.  
 
 
 
Figure 2. The structure of a value for money triangle.  
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The horizontal side of the triangle represents the cost associated with the intervention. The 
vertical side represents the additional expected benefit score. The larger the triangle, the 
larger the health benefit in the population. The higher the triangle, the more cost-effective 
intervention. Additional benefit can be gained from reduction of health inequality. (Airoldi 
et al. 2014: 970; Kunnamo 2016: 69.) 
 
To conclude, value-based healthcare concentrates on the effectiveness of interventions and 
treatments and is measured by health outcomes and improvements in patient’s health instead 
of the number of single visits in health centers. On population level, practicing value-based 
healthcare provides an opportunity to cost-effectiveness and reduction of health inequalities 
among patients. Various analytical methods, such as health benefit analyses can be used to 
reach the underserved patients and populations. The earlier the needed interventions are 
implemented, the better and more cost-effective health outcomes.   
 
 
2.2. Value and value co-creation in service systems 
 
Creation of value has traditionally been the core purpose and central process of economic 
exchange (Vargo, Maglio & Akaka 2008: 145). Regarding value and value co-creation, there 
are several recurring concepts which need to be explained and defined, in order to be able to 
understand and discuss the opinions on the characteristics of value co-creation presented by 
a number of researchers. Therefore, in this subsection, these concepts and related service 
logics and systems are introduced and discussed. Further, the value co-creation practices and 
service ecosystems are presented in the context of healthcare.  
 
2.2.1. Concept of value 
 
Although it is difficult to define and measure, value for customers, according to Grönroos 
(2008: 303), means that after a customer has been assisted by a self-service process or a full-
service process, he or she feels better off than before. For example, in successful healthcare 
service delivery, where the outcome has improved an individual patient’s health, value has 
been created for the customer. Also, Rantala & Karjaluoto (2016: 34) suggest that in the 
healthcare sector, the definition of value and value offering is based on the betterment of the 
patient’s condition. Sometimes value can be measured in financial terms, sometimes it can 
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be indicated through effects on revenues or wealth or gained through cost savings. Value is 
considered to have also an attitudinal component such as trust, affection, comfort, and 
easiness of use. In some cases, value can also be negative. (Grönroos 2008: 303.)  
 
Value and the nature of it has been debated already in the ancient times as in the 4th century 
B.C. Aristotle distinguished value into use value and exchange value in order to address the 
difference between things and their attributes. Use value, or value-in-use refers to collection 
of substances or things and the qualities associated with these, whereas exchange value, or 
value-in-exchange has been more difficult to explain. In contemporary research value-in-
exchange is referred to as goods-dominant (G-D) logic and exemplified with how value is 
created in the form of goods, e.g. an automobile, which is exchanged in the marketplace for 
money. (Vargo et al. 2008: 146.)  
 
Grönroos (2008: 298, 304) expresses his views on the issue with “when customers are using 
resources they have purchased, value is created as value-in-use”, and continues with a 
statement that is “value-in-exchange in essence concerns resources used as a value 
foundation which are aimed at facilitating customers’ fulfilment of value-in-use”, and draws 
a theoretical conclusion according to which value-in-exchange can exist only if value-in-use 
can be created.    
 
Further, Grönroos (2008: 298) claims that when value is viewed from the value-in-use 
perspective, the customers are regarded as the value creators. When a service provider adopts 
a service logic which enables its involvement in the customer’s value-generating processes, 
the service provider can become a co-creator of value with its customers. Hence, value co-
creation is a value generating process carried out in interaction between the supplier or 
service provider and the customer.  
 
Some scholars refer to the value co-creation phenomenon with different terminology. For 
example, Osborne, Radnor and Nasi (2012: 139) have studied service-dominant approach in 
public management and agree with that service is an intangible process in which production 
and consumption occur simultaneously, and where users are obligate co-producers of the 
outcome. Co-production as a term, however, characterizes more the goods-dominant logic 
which refers to transformation of raw materials into sellable goods. 
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Vargo et al. (2008: 145) define value co-creation as a phenomenon where value is created 
collaboratively in interactive configurations of mutual exchange and refer to these 
configurations as service systems. Moreover, it is stated that the service systems and value 
co-creation are studied within a discipline called service science.  
 
2.2.2. Service science and service-dominant (S-D) logic  
 
In this study, the business value and potential benefits of big data analytics are studied in the 
field of healthcare. To learn how the healthcare services are arranged and how healthcare 
works, the interaction between healthcare service providers, patients and other possible 
actors can be explored. Service science is the study of service systems and of value co-
creation within complex constellations of integrated resources. A service system is an 
arrangement of resources, such as people, competences, technology (e.g. algorithm) and 
information (derived from data) connected to other systems by value propositions. The 
purpose of a service system is to make use of its own resources to improve its circumstances 
and enhance that of others. In service systems, value is defined in terms of improvement in 
system well-being. In other words, value is not created until the well-being of a customer has 
improved in some way. (Vargo et al. 2008: 145, 149 – 150.) The definition of service science 
is applicable when examining healthcare service arrangements consisting of populations and 
patients as customers, and for example health centers with their professionals, equipment and 
supporting information systems as service providers.  
 
According to Vargo et al. (2008: 145), service is determined as the application of 
competences, such as knowledge and skills. In addition, Grönroos (2008: 300), brings into 
focus the fact that service can be viewed from three aspects, stating first that service is an 
activity, a process where someone does something to assist someone else, and then examining 
service from customer’s perspective as value creation, and from service providers perspective 
as business logic.  Further, Grönroos (2008: 299) separates the service logic from customer’s 
and service provider’s perspectives in the following way: 
 
“1. When using resources provided by a firm together with other resources and 
 applying skills held by them, customers create value for themselves in their 
 everyday practices (customer service logic). 
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  2. When creating interactive contacts with customers during their use of goods and 
 services, the firm develops opportunities to co-create value with them and for 
 them (provider service logic).” 
 
Service-dominant (S-D) logic, developed and introduced by Vargo et al. (2008), emerged 
when the traditional goods-dominant models of value creation concentrating only on firm’s 
output and price were challenged with new alternative perspectives. S-D logic is 
characterized with the notion of value co-creation that suggests that there is no value until an 
offering is used, and that the customer always need to participate in value co-creation (Vargo 
et al. 2008: 148). Grönroos (2011: 282 – 283) has however challenged this view of S-D logic 
and argues that the value creating activities of the service provider and customer cannot be 
included in the same analysis, and suggests that the service provider’s value creation is an 
all-encompassing process which is separate from the customer’s creation of value-in-use. 
Further, in case there is a mutual value-in-use creation between the service provider and 
customer, Grönroos (2011: 290 – 291) insists that it happens in “one merged coordinated 
interactive process”, and states that “if there are no direct interactions, no value co-creation 
is possible”. 
 
Interestingly, Rantala & Karjaluoto (2016: 34) agree with the definition of value co-creation 
where both parties create mutual value via cooperation, but also address the new mode of 
interaction in value co-creation as the digitization of the services is transforming the scene. 
The idea that value can be created only in direct interaction, is challenged as digitization of 
services has changed the traditional service-process thinking and technology has enabled 
both parties to act independently and not necessarily simultaneously (Rantala & Karjaluoto 
2016: 36). The new ways of interaction in value co-creation through digital platforms 
transforms value co-creation according to Rantala & Karjaluoto (2016: 40) so remarkably, 
that they suggest a paradigm shift in definitions of interaction and time-dependency. 
 
As indicated, the exploration of value co-creation has over the years raised lively debate 
among scholars. Thus, the definitions of it as well as the determining factors of S-D logic 
have now been encapsulated by Vargo & Lusch (2017: 47) and Lusch et al. (2016: 2957) in 
form of five axioms: 
 
“ 1. Service is the fundamental basis of exchange 
   2. Value is co-created by multiple actors, always including beneficiary 
 28 
 
 
   3. All social and economic actors are resource integrators  
   4. Value is always uniquely and phenomenologically determined by the           
 beneficiary     
   5. Value co-creation is coordinated through actor-generated institutions and      
 institutional arrangements”. 
 
Conclusively it can be argued, that in a service situation, value is co-created rather than 
created and delivered by one actor, and that the S-D logic represents a dynamic continuing 
narrative of value co-creation through resource integration and service exchange (Vargo & 
Lusch 2017: 47). Moreover, since the S-D logic represents a dynamic and continuing 
narrative of value co-creation, it has increasingly been introduced to new disciplines, such as 
data analytics and cognitive computing. Also, the continued research of value co-creation has 
resulted in studies where various service ecosystems have become more frequent units of 
analysis for value co-creation, for example in healthcare. (Vargo & Lusch 2017: 47, 58, 62.)  
 
2.2.3. Healthcare ecosystem and value co-creation practices  
 
Ecosystems are, in biological literature, defined as communities of organisms interacting 
over time and space with other organisms and other elements in the system. Markets, 
economies, and similar human systems are comparable with natural ecosystems because they 
change and emerge similarly over time. Interestingly, to capture this systemic dynamism, S-
D logic has identified the concept of service ecosystem. (Lusch et al. 2016: 2958.) 
 
A service ecosystem is defined by Lusch et al. (2016: 2958) as “a relatively self-contained, 
self-adjusting system of resource-integrating actors connected by shared institutional 
arrangements and mutual value creation through service exchange”. Moreover, when the 
five axioms of the S-D logic are coupled with the concept of service ecosystem, Vargo & 
Lusch (2016) formulate the process of value co-creation in the following way (Lusch et al. 
2016: 2958): 
 
“Value co-creation occurs through (social and economic) actors, involved in resource 
integration and service exchange, enabled and constrained by institutions and 
institutional arrangements, establishing nested and interlocking service ecosystems 
of value co-creation, which serve as the context for future value co-creation 
activities.” 
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As indicated in Figure 3, healthcare ecosystem consists of multiple levels and actors being 
more complex than a relationship between solely a doctor and patient (Frow et al. 2016: 27). 
The healthcare ecosystem is divided into four levels each consisting of various actors, such 
as people and organizations. The mega level involves government agencies defining the 
aspects of health policy, while on macro level e.g. state health authorities determine the 
allocation of funding. On meso level operate the hospitals and local health support agencies, 
and on micro level the co-creation practices involve doctors, nurses, and patients with their 
families. (Frow et al. 2016: 27.) 
 
 
 
 
 
Figure 3. Healthcare ecosystem (adapted from Frow et al. 2016: 27). 
 
As stated, the broader mega level issues concern mostly the policies set by the national 
governments. In this context, the ongoing healthcare reform in Finland can be addressed. 
According to the current political debate, the governmental actors on the mega level suggest 
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that after the reform is implemented, there will be a new actor on the macro level responsible 
for organizing the healthcare service, and on the meso level, there will be public and private 
healthcare service providers.  
 
Value co-creation practice is a resource integration process which involves actors sharing 
their resources during collaborative activities and interactions. For example, sharing 
resources such as electronic health records between hospitals and health centers results in 
more informed and relevant treatment for patients. The important role of practices is to link 
the actors within an ecosystem, as well as realize benefits for the actors and ensure the well-
being of the service ecosystem, and finally for the benefit of the patient. (Frow, McColl-
Kennedy & Payne 2016: 24, 26.)  
 
One purpose of the study by Frow et al. (2016: 30) was to identify and create a typology of 
co-creation practices in the field of healthcare and analyze whether the impact of the 
identified practices can be considered as positive or negative. They identified altogether eight 
co-creation practices (Table 1) that support the ecosystem well-being. This study highlights 
practices CP3, CP5, CP6 and CP7, because they might be positively impacted when health 
benefit analyses (cf. subsection 2.1.1.) are used as part of healthcare services. 
 
Table 1. Typology of co-creation practices and their indicative measures in healthcare (Frow 
et al. 2016: 31 – 33). 
 
 
Co-creation practices Examples of indicative measures 
CP1: Practices that endow actors 
with social capital 
Density or volume of interactions 
Degree of bonding, bridging, and linking actors 
Actor proximity in direct or intermediated 
interaction 
CP2: Practices that provide an 
ecosystem with shared language, 
symbols, signs and stories 
Extent that dissemination of symbols, signs and 
stories within ecosystem 
Extent of use/dissemination of symbols, signs and 
stories 
CP3: Practices that shape an actor’s 
mental model 
Change in co-creation practices/behavior/activities 
Change in actors’ worldview of their role within 
the whole ecosystem 
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Extent of adoption of customer-centered practices 
(e.g. patient-centered care model) 
CP4: Practices that impact the 
ecosystem, created or constrained by 
the physical structures and 
institutions that form their contexts 
The extent to which rules, norms, and procedures 
change over time together with their impact 
How changes to a structure or institution impact 
existing practices and support new practices 
CP5: Practices that shape existing 
value propositions and inspire new 
ones 
Extent of actor perceived change in focus or in 
direction of value proposition 
Articulation of new propositions 
Extent to which existing and new value 
propositions follow best-practice guidelines 
CP6: Practices that impact access to 
resources within an ecosystem 
Extent to which actors offer access opportunities 
and platforms for resource sharing 
Extent to which resources are shared by all actors 
within an ecosystem 
CP7: Practices that forge new 
relationships, generating interactive 
and/or experiential opportunities 
Extent to which practices create opportunities for 
forging new relationships within the ecosystem 
Extent to which actors engage in new co-creation 
practices 
Extent, strength and intensity of relationships 
within ecosystem 
CP8: Practices that are intentionally 
co-destructive creating imbalance 
within the ecosystem 
Defection of actors from the ecosystem 
The growth of new ecosystems that supersede 
original ecosystem 
Extent of conflicting roles of actors who belong to 
multiple ecosystems 
 
 
In addition, patients can also become active co-creators for their own health services when 
they are given more responsibility for maintaining their own health for example by eating 
healthier foods, exercising, and practicing self-care (Nordgren 2009: 121). However, there 
has been claims that patients are deemed to be in asymmetric position in relation to the 
healthcare providers, and thus incapable of making proper choices based on sufficient 
knowledge (Nordgren 2011: 309). In practice, according to Nordgren (2011: 309), there is a 
lack of system, which informs patients of the available options in terms of treatments, as well 
as risks and quality, and doctors fail to give patients information about alternative treatments 
on regular basis which lead to situations where the patients’ possibilities to choose are 
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strongly impaired. Hence, as suggested by Frow et al. (2016: 32), practices that inspire new 
value propositions, may solve the problem in form of e.g. health benefit analysis. 
 
Further, Payne, Storbacka & Frow (2008: 93 – 94) suggest that professionals can even teach 
the patients certain value co-creation behaviors by for example communicating expectations 
on how patients can actively participate in the co-creation of value. This can be compared to 
a situation where healthcare professional suggests a patient to stop smoking as an intervention 
to improve his health condition. If patient agrees and acts as suggested, value co-creation can 
be claimed to happen. 
 
Frow et al. (2016: 35) argue, that value co-creation practices have a central role in shaping 
an ecosystem, and that the co-creation practices they identified are especially relevant to 
healthcare and to the emerging trend toward putting the patient at the center of processes and 
structures related to their well-being. Again, in the context of the Finnish healthcare reform, 
the plan is, that on the micro level, the patient-centered approach will be in focus, thus 
providing the patient a freedom of choice regarding the healthcare service provider.  
 
Regardless of the national setup of the healthcare ecosystem, within it there are multiple 
interactions that occur with each level and across levels. Many actors are also involved 
directly and indirectly, within and across these ecosystem levels. (Frow et al. 2016: 28.)  
 
Besides that, Payne et al. (2008: 83, 88) agree with the discussion regarding the service 
science theme by arguing that the key feature of the service-dominant (S-D) logic is that the 
customer becomes a co-creator of value, they add that value co-creation through 
technological breakthroughs and innovative services offer new ways for service providers to 
engage customers in co-creation of value and customer experiences. For example, a 
healthcare service provider can engage patients in their own care and decision making related 
to it by offering services via new technology, digital platforms or through data-driven 
solutions.  
 
2.2.4. IT-enabled and data-driven value co-creation 
 
According to Storbacka et al. (2016: 3010), the value co-creating actors in an ecosystem can 
be humans or a collection of humans, such as organizations, but if limiting the view only on 
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human actors, the impact of technologies is ignored. However, service ecosystems are 
increasingly dependent on technology. Technological advancements in information 
technology (IT), such as digitization of services in various disciplines provide significant 
opportunities to study how it impacts the actors in an ecosystem, not only human but also 
other natural and artificial elements such as algorithms, and their interactions within the 
service ecosystem, for example in the field of healthcare. (Lusch et al. 2016: 2960.)  
 
Information technology enables the effective coordination of healthcare services, improve 
patient management, and play a key role in expanding access to healthcare services as it helps 
with connecting patients and health professionals, as well as provides patients an opportunity 
to act as active partners in their treatment (Quaglio et al. 2016: 314). For example, the use of 
electronic health records (EHR) and proving patients access to their own records, as well as 
embedding decision support tools in EHR systems have reportedly generated positive 
impacts on healthcare quality and better healthcare process quality (Bardhan & Thouin 2013: 
439).  
 
Demirkan et al. (2015: 734) agree by arguing that IT enables organizations to improve their 
inter- and intra-organizational collaboration, effectiveness, efficiency, and innovativeness by 
facilitating new types of services and creating possibilities for value co-creation with 
consumers, i.e. patients in the case of healthcare services. For example, a healthcare service 
provider can enable value co-creation with patients by providing an online booking system, 
telemedicine services, as well as improve effectiveness by sharing electronic health records 
among healthcare providers (Andrews et al. 2014: 376). 
 
According to Groves et al. (2013: 7), introducing big data in the service ecosystem in 
healthcare may be even changing the paradigm, as it enables the creation of feedback loop 
which keeps patients informed, provides opportunity to evidence-based care and selecting 
appropriate care provider, leads to sustainable approaches continuously enhancing healthcare 
value in form of cost reductions at the same or better quality, as well as provides opportunity 
for innovation. Consequently, according to Storbacka et al. (2016: 3010) the entities in such 
ecosystems are collections of arrangements of resources, including people, organizations, 
technology and information, e.g. big data, and advanced analytics of it.  
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To conclude, in service ecosystems value is co-created in interaction between various actors. 
In health ecosystem, there are specific value co-creation practices that can be identified and 
evaluated how they are affected or transformed when in addition to the digital actors, such 
as advanced analytics, is introduced in the ecosystem. 
 
 
2.3. Big data 
 
In information technology, data is the source of information and knowledge. The value of it 
lies in its use, which varies over time, place, and context. If data is in isolation, it has no 
meaning or value. Data can be of wide range of value, but it is often found only long after it 
has been collected and organized, or the value of it is understood only after it is lost. 
(Borgman 2015: 3 – 4.)  Since 1990s, companies have been storing large volumes of data 
(Delen 2014: 232), and the amount of collected and stored data from various sources in 
multiple formats has increased exponentially, which has led to the rise of the concept of big 
data (Demirkan et al. 2015: 735). Regarding the value of big data, it has been compared to 
oil of modern business and the glue of collaboration. It is expected to reveal the hidden 
treasures in the bit streams of life. (Borgman 2015: 3). To uncover the value of big data to 
healthcare, Archenaa & Mary Anita (2015: 407 – 408) recommend also governments to 
harness it for use in order to improve quality and minimizing the costs, and to enable value-
based healthcare for patients. 
 
2.3.1. Definitions of big data 
 
Big data means different things to different people, and traditionally the term has been used 
to describe massive volumes of data analyzed by huge organizations such as Google or 
research science projects at NASA (Delen 2014: 231; Demirkan et al. 2015: 734). In 
healthcare, according to the European Union (2016: 11), big data refers to large routinely or 
automatically collected datasets, which are electronically captured and stored. It is reusable 
in the sense of multipurpose data and comprises the fusion and connection of existing 
databases for the purpose of improving health and health system performance. It does not 
refer to data collected for a specific study. 
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The dimensions of big data are in the literature often defined with varying number of big 
data V’s. For example, IBM data scientists (2017) break big data into four V’s: volume – 
scale of data, velocity – analysis of streaming data, variety – different forms of data, and 
veracity – uncertainty of data. Gartner (2017a) in turn, characterize big data the V’s being 
high in nature, e.g. high-volume, high-velocity and/or high-variety information assets that 
demand cost-effective, innovative forms of information processing that enable enhanced 
insight, decision making, and process automation. 
 
As the number of V’s and characteristics of big data presented in the literature are variedly 
defined, a summary of the V’s and respective definitions or described characteristics are 
presented in Table 2. 
 
Table 2. Summary of the seven big data V’s definitions and characteristics. 
 
 
Big data ’V’ Definition / Characteristics Source 
Volume Large amounts of data 
 
Refers to the scale and the size of data 
 
 
The data comes in large amounts 
Berman (2013: xx) 
 
Sakr & Elgammal 
(2016: 50) 
 
Sahay (2016: 420) 
Velocity The content of the data is constantly changing, 
through the absorption of complementary data 
collections, through the introduction of 
previously archived data or legacy collections, 
and from streamed data arriving from multiple 
sources 
 
Represents the streaming data and large-volume 
data movements 
 
Concerns data in motion/streaming data, 
bandwidth, and how fast data is being produced 
and how fast it must be processed to meet the 
needs/demands 
 
The data has a real-time and continuous nature 
Berman (2013: xx) 
 
 
 
 
 
 
Sakr & Elgammal 
(2016: 50) 
 
Demirkan et al. 
(2015: 735) 
 
 
 
Sahay (2016: 420) 
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Variety /  
Variability 
The data comes in different forms, including 
traditional databases, images, documents, and 
complex records 
 
Refers to the complexity of data in many 
different structures 
 
Concerns data’s many forms (i.e. structured, 
unstructured, text, multimedia, video, audio, 
sensor data, meter data, html and so on) 
 
The data (structured and unstructured) have 
different sources 
Berman (2013: xx) 
 
 
 
Sakr & Elgammal 
(2016: 50) 
 
Demirkan et al. 
(2015: 735) 
 
 
Sahay (2016: 420) 
Veracity Concerns data in doubt, e.g. uncertainty due to 
data inconsistency and incompleteness, 
ambiguities, latency, deception, accuracy, 
quality, truthfulness, or trustworthiness of data 
 
The data can be triangulated from multiple 
sources 
Demirkan et al. 
(2015: 735) 
 
 
 
Sahay (2016: 420) 
Validity The data reflects primary sources of collection Sahay (2016: 420) 
Volatility The data is available over time Sahay (2016: 420) 
Value  
 
Potential of big data to be utilized for 
development 
 
 
Concerns data for co-creation, the relative 
importance of data to the decision-making 
process 
 
The use value of big data represents how it helps 
to address problems and use conditions, while 
the exchange value of big data represents its 
reusable intellectual capital and how it is used in 
multiple contexts to generate value 
United Nations 
Global Pulse  
(2013: 2) 
 
Demirkan et al. 
(2015: 735) 
 
 
Sahay (2016: 421) 
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Berman (2013: xx) emphasizes that it is important to distinguish big data from ‘massive data’ 
or ‘lots of data’, and claims that at least volume, variety, and velocity of the V’s must apply 
in order to fulfill the definition of big data.  
 
Delen (2014: 237) claims that velocity may be the most overlooked characteristics of big 
data, but too important to be ignored as when data is created it starts to age and degrade and 
its value proposition becomes worthless, for example, in healthcare, the capability to access 
and process patient data quickly creates more advantageous outcomes for the patient. 
Raghupathi & Raghupathi (2014: 10) agree with this by arguing that real-time big data 
analytics is a key requirement in healthcare. Delen (2014: 238) continues by stating that the 
excitement around big data is created by its value proposition, which promises that by 
analyzing large and feature-rich data, organizations can gain greater business value than they 
could by detecting patterns in small datasets or by using simple statistical methods and 
concludes with statement “big data means big analytics”.  
 
The origin of big data is versatile (IIHT 2013: 6), and according to Delen (2014: 232) big 
data comes from everywhere. As the three-level diagram in Figure 4 depicts, variety and 
velocity, as well as volume of data increases when the traditional databases are first 
complemented with mostly human-generated complicated data from the internet and social 
media and grows even more when machine and sensor generated data is added to the big data 
set.  
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Figure 4. The wide range of sources for big data (Delen 2014: 233). 
 
For example, in healthcare, big data can be collected in various formats from diverse sources, 
such as internet-based text documents, internet search indexes, sensor networks, social 
networks, global positioning systems (GPS), biology, genomics, biochemical experiments, 
medical records, scientific research, as well as genomic/biomed research (Demirkan et al. 
2015: 735), and further, data in healthcare come in structured format from electronic health 
records (EHRs), or electronic medical records (EMRs), while semi-structured data may 
include instrument readings or converted paper records to electronic health records. In 
addition, structured and unstructured data can be streamed into healthcare systems from 
fitness devices, genetics and genomics, social media, and other sources. (Sakr & Elgammal 
2016: 50.) According to Archenaa & Mary Anita (2015: 409) the big data sources in 
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healthcare refer to the patient data such as doctors’ notes, laboratory reports, x-ray images, 
national health register data, and even to RFID data of surgical instruments. In addition to 
patient related data, big data in healthcare settings may include also evidence-based medicine 
systems which doctors have traditionally been using to support decision-making (Sakr & 
Elgammal 2016: 56).  
 
The above discussed characteristics and V’s of big data respectively provide challenges to 
consider when planning how to gain value from it. The challenges and critical success factors 
of big data analytics are presented in the following subsection. 
 
2.3.2. Identified challenges and critical success factors 
 
Sivarajah et al. (2017: 263) performed a holistic review on big data and big data analytics to 
gain understanding in the landscape with the objective of making robust investment 
decisions. Based on their review, they concluded that big data challenges can be grouped into 
three main categories based on data lifecycle: data, process, and management challenges. 
 
Data challenges relate to the characteristics of the data itself, e.g. data volume, variety, 
velocity, veracity, volatility, as well as discovery, quality, and dogmatism. Process 
challenges are related to a series of how techniques: how to capture data, how to integrate 
data, how to transform data, how to select the right model for analysis and how to provide 
the results. Management challenges cover for example privacy, security, governance, and 
ethical aspects. (Sivarajah et al. 2017: 265.) Since these challenges are presented on a general 
level, it can be assumed that they are universal and therefore they concern most industries 
utilizing big data and big data analytics, including healthcare.  
 
The success of big data analytics in turn, depends on many critical factors (Figure 5), which 
according to Delen (2014: 240 – 241) need to be clarified and in place before investing in 
any systems or starting the analytics efforts. There should be most of all, a clear business 
need for performing big data analytics, aligned with the current vision and strategy of the 
organization. It is also important to find personnel with analytical skills, choose the right 
analytics tools, and ensure a strong committed sponsorship from the executive level, as 
without it, it would be difficult of even impossible so succeed.  
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Figure 5. Critical success factors for big data analytics (Delen 2014: 240). 
 
 
Generally, the purpose of various data analytics, such as business analytics is to provide 
insight for problem solving and decision making. Regardless they are not the same, often the 
terms analysis and analytics are used to refer to the same thing. To determine the term 
analytics, Delen (2014: 1) suggests that “analytics is the art and science of discovering 
insight by using sophisticated mathematical models along with variety of data and expert 
knowledge”, and further “these days, analytics can be defined as simply as the discovery of 
meaningful patterns in data”. Moreover, Delen (2014: 3) argues that "analytics is a variety 
of methods, technologies, and associated tools for creating new knowledge/insight to solve 
complex problems and make better and faster decisions”, and “analytics is multifaceted and 
multidisciplinary approach to addressing complex situations”.  
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Hence, big data analytics and modern data mining are relatively new concepts, which also in 
different scope and contexts are often referred to using diverse terminology. Big data 
highlights the challenges related to the increased large data streams, which have been 
addressed with recent advancements in hardware, software, and algorithms. Data mining 
refers to mining corporate data to discover new and useful knowledge to improve business 
and its practices. Data mining plays a key role in analytics, it is “the process of discovering 
new knowledge in the patterns and relationships in large data sets”. (Delen 2014: 1, 4, 14, 
32 – 33.)  
 
 
 
Figure 6. The continuum of data to information to knowledge (Delen 2014: 33).  
 
 
Basically, data can be any data in any format, or even a combination of various data sources, 
i.e. big data. Data is facts, whereas information is organized and processed data, and 
knowledge is information which is contextual, relevant, and actionable (Figure 6). For 
example, according to IIHT (2013: 7) electronic health records coupled with analytical tools 
provide through data mining opportunity to information enabling earlier disease detection, 
more effective outcomes across large populations, and by that means improved population 
health management. 
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2.3.3. Taxonomy of analytics 
 
The analytics are classified according to a simple taxonomy of analytics developed by Delen 
(2014: 16 – 17), into three categories, namely descriptive, predictive, and prescriptive 
analytics, each distinguished by the type of the data used and purpose of the analysis. 
According to Delen (2014: 16) most organizations begin with descriptive analytics and then 
move to predictive analytics and finally to prescriptive analytics which is the most advanced 
level of analytics. Further, he points out that moving from a lower analytics level to a higher 
is not clearly separable, as a business can be in the descriptive analytics level while at the 
same time already use partially either of the more advanced level analytics, too. The 
classification of analytics into descriptive, predictive, and prescriptive is also used by other 
scholars in their research, for example Sivarajah et al. (2017: 266), Wang, Kung, Wang & 
Cegielski (2017: 2 – 3) and Wang & Hajli (2017: 289).  
 
As mentioned, descriptive analytics is the entry level in analytics taxonomy, and it is often 
referred to as business reporting, which provides an answer to questions such as what 
happened and what is happening? Delen 2014: 16). Wang & Hajli (2017: 289) agree with 
this as they state that descriptive analytics provides the ability to describe the data in summary 
form for exploratory insights and to answer to what has happened in the past. Sivarajah et al. 
(2017: 275) in turn state that descriptive analytics is used to identify patterns and create 
reports concerning past behavior, and therefore considered as backward looking and 
revealing only what has already happened.  
 
According to Delen (2014: 16), organizations are mature to move to predictive analytics once 
they are ready to look beyond what happened and able to answer to question what will 
happen? Predictive analytics allow users to predict or forecast the future (Wang & Hajli 
2017: 289; Delen 2014: 17) for a specific variable based on the estimation of probability, and 
it also enables users to develop predictive models to identify causalities, patterns, and hidden 
relationships. Predictive analytics provides the ability to process large volumes of both 
structured and unstructured data, as well as supports the data processing in real-time of near 
real-time. (Wang & Hajli 2017: 289.) Sivarajah et al. (2017: 276) summarize that predictive 
analytics aims to predict the future by analyzing current and historical data.  
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Prescriptive analytics uses optimization-, simulation- and heuristics-based decision-
modelling techniques and tries, according to Delen (2014: 18), to answer to the question what 
should I do? Prescriptive analytics can continually re-predict and automatically improve 
prediction accuracy by taking in new combined structured and unstructured datasets to 
develop more thorough decisions (Wang & Hajli 2017: 289 – 290). Sivarajah et al. (2017: 
277) explain prescriptive analytics with an example where what if simulators help in decision 
making by providing insights regarding plausible options that a business can choose to 
implement in order to maintain or strengthen its position in the market. A comparable 
situation in healthcare could be when analytics is providing insights regarding alternative 
interventions that a patient can choose in order to maintain or improve his or her health. 
 
Descriptive analytics is also called business intelligence (BI) while predictive and 
prescriptive analytics are collectively called advanced analytics. The shift from descriptive 
analytics to the more sophisticated analytics is significant, since it warrants that the analytics 
is advanced. (Delen 2014: 16.)  
 
Moreover, beyond this taxonomy, predictive analytics which employs complex algorithms 
with learning ability, may be even further classified as machine learning (ML), which excels 
at identifying latent patterns and connections that humans are too evolved to perceive 
(Sivarajah et al. 2017: 276; Barlow 2016: 11). Machine learning is a type of artificial 
intelligence (AI) that allows software applications to become more accurate in predicting 
outcomes without being explicitly programmed (TechTarget 2017). According to Gartner 
(2017b), “advanced machine learning algorithms are composed of many technologies, such 
as deep learning, neural networks and natural-language processing used in unsupervised 
and supervised learning, that operate guided by lessons from existing information”. An 
example of artificial intelligence, is IBM’s Watson, which is characterized as “smart” 
machine with human mind, designed to answer questions posed in natural human language. 
Watson is capable to analyze natural language, identify sources, find and generate 
hypotheses, find and score evidence, and merge and rank hypotheses. (Delen 2014: 20 – 21.) 
Similar artificial intelligence applications are developed continuously for various purposes, 
also in the field of healthcare.  
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2.3.4. Big data analytics in healthcare 
 
Many businesses are operating in challenging and complex environments with an ever-
increasing amount of diverse data. Therefore, to gain knowledge and get support for decision-
making based on the best available evidence, businesses have begun to invest in data 
analytics by consciously shifting into data and evidence-driven business practices (Delen 
2014: 4). In healthcare, to gain insight for better informed decisions concerning patients’ 
health, the healthcare service providers have started to use their very large data sets for big 
data analytics, as its potential to improve care and save lives at lower cost have been 
identified (Raghupathi & Raghupathi 2014: 1, 5). Moreover, according to Delen (2014: 24), 
due to the fact that healthcare struggles with an imbalance between demand and supply, and 
increasing prices and decreasing quality, systems that has the ability to help in diagnosing 
and treating patients by analyzing large amounts of data, are needed. 
 
The variety of healthcare data is large, as analytics typically aggregates data from several 
real-time data sources consisting of multiple data formats. Sources used in advanced data 
analytics can be various databases, records and systems, for example electronic health 
records (EHR), clinical decision support systems, as well as web and social media data (e.g. 
clickstream and interaction from Facebook, blogs, health plan websites, smartphone apps), 
machine to machine data (readings from remote sensors, meters and other vital sign devices), 
biometric data (e.g. finger prints, genetics, x-ray and other medical images, blood pressure, 
pulse and pulse-oximetry readings), and human generated data (e.g. email, paper documents). 
Data types can vary from structured data, e.g. traditional electronic health care records, and 
semi-structured data, e.g. the logs of health monitoring devices, to non-structured data, such 
as notes or clinical images. The analytics tools and architecture for structured and 
unstructured big data differ from traditional data management and business intelligence tools 
where the data is assumed to be certain, clean, and precise. (Raghupathi & Raghupathi 2014: 
4 – 5; Wang et al. 2016: 2 – 3.) 
 
Handling data from various sources is challenging because the characteristics of the collected 
data might vary considerably (Wang et al. 2016: 2). For example, as big data is often 
unstructured, messy, and dirty it means that the organizations need to have ability and 
capability to handle the fast arriving data so that it can be converted into actionable insight 
(Delen 2014: 8). Regardless which data sources or formats are used, the veracity of the data 
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needs to be validated before analyzing it, meaning that it must be ensured that the analyzed 
data is of high quality, truthful, and accurate by making sure that the diagnoses, interventions, 
and outcomes are captured correctly in the data sources (Raghupathi & Raghupathi 2014: 4).  
 
Obermeyer & Lee (2017: 1211) are concerned regarding the data analyzed with highly 
accurate algorithms and bring out some criticism for the veracity of the data. They warn that 
ignoring clinical thinking and relying solely on analytics is dangerous, as the analyzed data 
is always based on human decisions and human mistakes, which can lead to failures. 
Therefore, it is important to consider analytics as thinking partners, not replacements for 
doctors, who need to be trained to utilize analytics to master the complexity of modern 
medicine and patients with more coexisting illnesses and medications (Obermeyer & Lee 
2017: 1209, 1211). 
 
According to Delen (2014: 9), some criticism has been brought out also toward data and data 
analytics, most commonly regarding security and privacy issues due to the risk of breaches 
of sensitive information and leaking or misuse of personal data. Moreover, Gumbus & 
Grodzinzky (2016: 118) raise their concerns of the rise of computational power and cheaper 
and faster devices to capture, collect, store and process data which can lead to “datafication” 
of society and cause discriminatory practices as its side effects, e.g. in a situation where 
analytics lead to harmful or unfair outcomes for individuals or populations.   
 
However, despite of the hurdles in the way, big data analytics is a powerful tool, as it enables 
organizations to gain new insights into organizational knowledge, which can be used in 
decision making and action taking. Using this kind of advanced analytics is not only a matter 
of increased productivity or efficiency, but also of intangible values such as increased 
flexibility and quality improvement. (Wang, et al. 2017: 3 – 4.) 
 
 
2.4. Big data analytics-enabled transformation model 
 
To find out the business value and potential benefits of big data analytics for the healthcare 
industry, Wang & Hajli (2017: 287) developed a big data analytics-enabled business value 
model using the resource-based theory and capability building view. The theory models the 
big data analytics components, capabilities, and benefit dimensions, but does not build a view 
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on value co-creation practices related to healthcare service delivery. Another theory 
addressing the same subject is the big data analytics-enabled transformation (BDET) model 
(Figure 7) developed by Wang et al. (2017: 2) who supplement the model with a practice-
based view from strategic management to explain how big data analytics can enable 
organizations to develop inimitable practices, which in turn are intended to create business 
value.  
 
 
 
Figure 7. Big data analytics-enabled transformation model (Wang et al. 2017: 2). 
 
The model aims to explain how big data analytics capabilities can create potential benefits 
and business value for a healthcare organization (Wang et al. (2017: 2). The linear progress 
path of the model follows a practice-based view developed by Bromiley & Rau (2014: 1252 
– 1253), who argue that practices are important entities in and of themselves, rather than 
simply indicators for some underlying construct. 
 
Hence, both theories and developed models seek to discover the potential benefits and 
business value of big data analytics in healthcare context, but as the big data analytics-
enabled transformation model by Wang et al. (2017: 2), also includes the practice-based 
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view, it is more suitable for this study because these practices, even though intended to be 
inimitable, can be viewed from the value co-creation perspective as well. The BDET model 
is explained in more detail in the following paragraphs. 
 
2.4.1. Components of BDET model 
 
Explanatory variables  
 
The explanatory variables of this model refer to the big data analytics capabilities generated 
from big data analytics resources, that are big data analytics architectural components. The 
resources that together build the analytic capabilities consist among others of the data itself, 
managerial and technical skills, and data-driven culture of the organization. Further, the tools 
and functionalities of big data analytics are identified to consist of three architectural 
components, namely data aggregation, data analysis and data interpretation which allow 
users to transform data into evidence-based decisions and informed actions. (Wang et al. 
2017: 2.)  
 
Data aggregation component aims to collect heterogeneous data from multiple sources, e.g. 
data warehouses and databases, and transform it into specific data formats which can be read 
and analyzed. In this phase, according to Wang & Hajli (2017: 289), after data is collected 
and extracted from various sources, data analysis component explains how all kinds of data 
is processed (e.g. data mining or natural language processing) and how analyses are 
performed so that they support evidence-based decision making and meaningful practices in 
healthcare organizations. Data interpretation component generates general clinical 
summaries such as historical reporting, statistical analyses, time series comparisons, provides 
data visualizations and real-time reporting such as alerts, proactive notifications, and 
operational key performance indicators (KPIs), as well as meaningful business insights 
derived from the analytics components. (Wang et al. 2017: 2 – 3, 6.) 
 
To evaluate the analytics capabilities, the model breaks them down into traceability which 
refers e.g. to the capability of tracking medical events and searches in clinical databases; 
analytical capability which refers to the nature of the analysis, e.g. understanding the past 
and current state of variables, causes of occurred medical events and support of real-time 
processing; decision support capability which refers to real-time or near real-time clinical 
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summaries presented in visual dashboards; and predictive capability which refers to the 
capability to examine undetected correlations, patterns and trends between specific variables, 
compare current and historical data, predict future trends, and provide actionable insights or 
recommendations in readable format (Wang et al. 2017: 6 – 7). Wang & Hajli (2017:290) in 
turn, base their definition in information lifecycle management, and define big data analytics 
capability in the healthcare context as “the ability to acquire, store, process and analyze large 
amounts of health data in various forms, and deliver meaningful information to users, which 
allows them to discover business values and insights in a timely fashion”. 
 
IT-enabled transformation practices 
 
The BDET model explores seven different IT-enabled practices listed in Table 3. The 
practices are classified into localized exploitation, internal integration, business process 
redesign, business network redesign, and business scope redefinition. The two first 
classification levels are evolutionary transformation level practices and the last three are 
considered to be revolutionary transformation level practices. (Wang et al. 2017: 2 – 3, 7.) 
 
 
Table 3. IT-enabled transformation practices with examples (Wang et al. 2017: 7).  
 
 
Classification of IT-enabled 
transformation practice  
Examples 
Localized exploitation: 
1. Meaningful use of EHR  
(electronic health record) practice  
 
Generate lists of patients by specific conditions 
to use for reduction of disparities, research or 
outreach 
Improve care coordination among healthcare 
units through interoperable EHR systems 
Localized exploitation: 
2. Evidence-based medicine practice  
 
Explore the fact from medical events or patient 
treatments to improve specific outcome 
Build holistic view of evidence by insights from 
literature-based data and research studies 
Internal integration: 
3. Multidisciplinary practice  
 
Provide joint decisions regarding treatments to 
patients from a multidisciplinary team 
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Business process redesign: 
4. Clinical resource integration 
practice  
 
Allocate resources to serve each healthcare unit 
Create centralized information support for 
clinical operation 
Business network redesign:  
5. Network collaboration practice  
 
Build common understanding of healthcare 
service between care providers and other 
stakeholders 
Business network redesign:  
6. Network knowledge creation 
practice  
 
Allow all stakeholders to share information on 
the platforms 
Discover new knowledge by enabling 
stakeholders to collaboratively map ideas 
Business scope redefinition: 
7. Personalized care practice  
 
Create personalized disease risk profile and 
disease and wellness management plan for each 
patient 
 
 
The IT-enabled transformation practices presented in the BDET model can be linked to the 
co-creation typology (Table 1) introduced by Frow et al. (2016: 31 – 33). For example, 
personalized care practice can be linked with the practices that shape an actor’s mental model 
and practices that shape existing value propositions and inspire new ones (CP3 and CP5). 
Also, clinical resource integration practices can be linked with practices that shape an actor’s 
mental model (CP3), as they are affected by how the personalized care practices are arranged.  
In addition, meaningful use of EHR and evidence-based medicine practices can be linked 
with the practices that impact access to resources within an ecosystem (CP6), e.g. in form of 
shared knowledge resources. Multidisciplinary practices, network collaboration practices and 
network knowledge creation practices can be linked to the practices that forge new 
relationships, generating interactive and/or experiential opportunities (CP7), e.g. when 
collaboration between various specialties in hospital or cross-boundary cooperation between 
health and social sectors are developed. 
 
Intermediate outcomes 
 
Wang et al. (2017: 2 – 3) treat intermediate outcomes in the BDET model as benefits. To 
conceptualize the potential benefits, they apply a multidimensional information system (IS) 
benefit framework developed by Shang & Sheddon (2002: 277 – 280) who have identified 
five benefit dimensions in their research. Also, Wang & Hajli (2017: 293) use this benefit 
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framework and provide some examples on practical benefits. The benefit dimensions and a 
summary of selected examples are listed in Table 4. 
 
Table 4. The benefit dimensions with examples of subdimensions (Shang & Sheddon 2002: 
277; Wang et al. 2017: 3; Wang & Hajli 2017: 290, 293). 
 
 
Benefit 
dimensions  
Description  Examples of subdimensions 
Operational 
benefits  
The benefits obtained from the 
improvement of operational 
activities 
Productivity improvement 
Quality improvement 
Customer service improvement 
Cycle time reduction 
Cost reduction 
Immediate access to clinical data 
for analysis 
Enable proactive treatment before 
the condition worsens 
Managerial 
benefits 
Benefits obtained from business 
management activities, e.g. 
allocation and controlling of 
resources, monitoring of 
operations, and supporting 
business strategic decisions 
Better resource management 
Insights and sound information for 
decision-making and planning 
Performance improvement 
 
Strategic 
benefits 
Benefits obtained from strategic 
activities involving long-range 
planning regarding high-level 
decisions 
Support for business growth 
Support for business alliances 
Building business innovations 
Achieving business competitive 
advantages: cost leadership, 
differentiation, and focus 
Comprehensive view of treatment 
delivery for meeting future needs 
IT 
infrastructure 
benefits  
Sharable and reusable IT 
resources providing foundation 
for present and future business 
applications 
Increased IT infrastructure 
capability 
Reduce of system redundancy 
Transfer data quickly among 
healthcare IT systems 
Simplified IT management 
IT cost reduction  
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Organizational 
benefits 
Benefits related to 
organization’s focus, cohesion, 
learning, and execution of 
chosen strategies  
Seamless and coordinated patient 
experience delivery 
Changing work patterns 
Facilitating organizational learning 
Cross-functional communication 
and collaboration 
Building common vision 
 
Organizational performance 
 
In the BDET model, organizational performance refers to business value (Wang et al. 2017: 
2). Both Wang et al. (2017: 3) and Wang & Hajli (2017: 290) argue that using Shang & 
Sheddon’s framework helps to understand the potential benefits of big data analytics and 
enhance the understanding of the business value of big data. It also acts as a tool for managers 
to assess the benefits of their firm’s information systems, which means that the model could 
also be used as a general model and guideline for assessment and classification of benefits 
from IT architecture.  
 
2.4.2. Big data-enabled transformation and value co-creations practices 
 
Since one of the objectives of this study is to indicate the possible transformation of selected 
value co-creation practices and evaluate their impacts to the healthcare ecosystem, the IT-
enabled transformation practices of the BDET model are viewed as value co-creation 
practices (cf. Frow et al. 2016: 31 – 33). Additionally, this enables the disclosure of the nature 
of the indicated transformation of the value co-creation practices, which can be considered 
as evolutionary or revolutionary. Another objective of this study is to discover the potential 
benefits and value from several stakeholder groups’ viewpoints. Therefore, in addition to the 
business value perspective, the model is extended with viewpoints of value for individual 
patients and population health. The individual patient’s perspective is important to 
understand in order to be able to develop the personalized patient centric care and motivate 
the patients to participate and acquire a more active role in their own care planning and shared 
decision-making. Regarding the population health perspective, it is essential to understand 
the generated value because it provides insights on how healthcare services should be 
targeted to close the indicated care gaps, which further supports the desired shift into value-
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based healthcare. Hence, the extended BDET model studies the value of big data analytics 
for three stakeholders. In case the findings show clear paths-to-value, they can also be 
illustrated with this model. 
 
Regarding the explanatory variables, big data analytics resources are studied through 
breakdown into data aggregation, data analysis, and data interpretation, and the capabilities 
in turn through breakdown into traceability, analytical capability, decision support capability, 
and predictive capability (Wang et al. 2017: 6, 10).  
 
To conclude, the original BDET model is extended as explained (Figure 8), and used for 
studying and analyzing the case, i.e. the Health Benefit Analysis tool, developed in a project 
funded and run by Sitra. The case, and the development project are introduced in more detail 
in chapters 3 and 4.  
 
 
 
Figure 8. The extended big data analytics-enabled transformation model (adapted from 
Wang et al. 2017: 2). 
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The big data analytics-enabled transformation model is aligned with the research questions 
and applied for studying and analyzing transformation practices as value co-creation 
practices and evaluating the performance with business value extended with value for 
individual patients and population health. 
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3. METHODOLOGY 
 
In this chapter, the choices regarding the methodology of this study are presented and 
justified. First, the research type is indicated, then the selected strategy and approach of the 
study are presented, continued with research design through selected research method and 
decisions regarding empirical data collection methods and analyzing process. In the end of 
this chapter, the validity and reliability of the study are discussed.   
 
The purpose and objective of this study is to find out how using advanced analytics of big 
data can create potential benefits and value for selected stakeholders, and how it affects the 
value co-creation practices in the selected service ecosystem. This objective explores a 
situation explaining the relationship between variables, that is the relationship between 
analytical capabilities of advanced analytics and performance, i.e. value created for the 
stakeholders. Also, the relationship between current and transformed value co-creation 
practices is addressed in the study. By that means the type of this study can be considered 
explanatory. However, as the study also provides insights into a relatively new field, and 
since there is an indicated research gap of potential business value through big data analytics 
in healthcare context, the type of study can also be regarded as exploratory. (Yin 2009: 9.) 
 
 
3.1. Research method 
 
In business research, case studies are popular research methods, suitable especially for 
investigating contemporary phenomena within real-life contexts. In a practical business-
related case study, the researcher can study even complex business issues by depicting the 
specific research problem, collecting, and analyzing empirical data, and in the results, suggest 
or recommend how to overcome the problem in this specific business context. (Eriksson & 
Kovalainen 2008: 116, 118.) Moreover, Maylor & Blackmon state that when the study is 
limited and exploratory in nature, a case study is useful and the most suitable methodological 
choice (2005: 243). 
 
As this study examines a specific complex business issue using a specific Health Benefit 
Analysis (HBA) tool as a unit of analysis, the selected research strategy is a single case 
study. At the time of this study, the development of the HBA tool was at the pilot stage. The 
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HBA tool is a suitable case for this study in terms of its analytical features and value promise, 
as well as due to the availability of the subject matter experts for interviews. In addition, 
according to Yin (2009: 13), a case study has distinct advantages when a how question is 
being asked about a contemporary set of events over which the researcher has little or no 
control.  
 
The research approach of this study is deductive as the research proceeds from theory to 
empirical testing. In deduction, also the literature leads to hypothesis or research question. 
The process of deduction is linear and follows the logic of proceeding from theory to 
empirical study. (Eriksson & Kovalainen 2008: 21 – 22; Maylor & Blackmon 2005: 150.) In 
this study, the empirical data collected in semi-structured interviews and from other sources 
are evaluated using the selected theoretical model acting as starting point for what is already 
known about the phenomenon. However, the theoretical model is slightly modified before it 
is used for empirical testing. The reason for modification is the interest to examine the 
performance from extended viewpoints and to study the practices not only from information 
technology but also from value co-creation perspective. For knowledge production in 
business research an adequate approach is to use the qualitative research methodology 
(Eriksson & Kovalainen 2008: 5). As this study aims at explanatory and holistic 
understanding of the studied issue, the qualitative approach is the methodological choice in 
this study. The choices regarding the research design are explained in the following 
subsections. 
 
Research design refers to the logical sequence that connects the empirical data to the initial 
research, i.e. the logic that links the data to be collected and the conclusions to be drawn to 
the initial questions of the study (Yin 2009: 24, 26). As stated above, the framework for 
conducting this study is a qualitative single case study. In case study, a phenomenon in a 
selected unit of analysis is explored in detail using a variety of methods, usually over a period 
of time. In this study, the single case study research method is used since the case is a unique 
tool, and because the study is evaluating the empirical data to learn whether the propositions 
of the theoretical model can be identified (Yin 2009: 47). The time horizon of this study is 
cross-sectional as the data was collected at a certain point of time, namely when the case tool 
was about to enter the pilot phase, where it is implemented for test use in selected health 
centers.  
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3.2. Sampling and case selection process 
 
The criteria for selecting the case for this study were 1) the case presents a real-world 
implementation of advanced analytics of healthcare big data and 2) its value promise includes 
generating benefits and value for individual patients, populations, and healthcare service 
providers. The boundaries of the selected case are limited to a single tool (Maylor & 
Blackmon 2005: 244), that fulfills the mentioned criteria, and contributes to answering to the 
research questions. 
 
The selected case, the HBA tool, was found via the Finnish Innovation Fund Sitra, which is 
the sponsor of the HBA tool development project. The HBA tool is developed in Finland and 
it uses data from various sources, including electronic health records of Finnish citizens. The 
value promise includes reduced care gaps and equal opportunities to healthcare in timely and 
cost-effective manner, which also meets the set selection criteria.  
 
The HBA tool development project has multiple goals where the main objective is to develop 
an analysis tool, which can analyze health data combined from various sources, and indicate 
patients suffering from potential care gaps, or cases of overtreatment. The aim is to develop 
a personal and systematic care need assessment which ensures access to treatment early 
enough for everyone that will benefit from the particular treatment, as well as reduce health 
inequalities among population (cf. Airoldi et al 2014: 965, 970). The purpose of the HBA 
tool is also to improve the cost-efficiency of healthcare services in Finland and facilitate a 
broader analysis of the overall status of disease treatment, such as having to do with 
medication, and, in turn, develop healthcare services to better meet the needs of various 
patient groups. Moreover, the developers aim to commercialize the HBA tool, targeted to 
both domestic and international markets. (Sitra 2016.) 
 
To find out how the expected benefits and values are achieved, and how using advanced 
analytics affects the related value co-creation practices, a sample of organizations and people 
were used. In order to build a comprehensive view of the case, an interviewee (Maylor & 
Blackmon 2005: 63) was selected from each development project participant organization, 
as well as several experts representing stakeholder organizations conducting parallel 
development closely related to the HBA tool. This sampling method represents non-
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probability or purposive deliberate sampling. More specifically, the sampling method in this 
study is convenience sampling where the sample is selected based on the ease of access. Also, 
the judgement sampling is used as the researcher’s judgement is used for selecting the 
interviewees in the case. (Kothari 2004: 15.) 
 
 
3.3. Data collection and analysis 
 
In case studies, the empirical data can be retrieved from multiple sources. In business-
research, the primary source of empirical data are in-depth interviews. In addition, other 
sources can be used to complement the data collected in interviews. Other sources are for 
example documents such as minutes of meetings, letters, reports, statistics, archival records, 
articles, as well as digital materials such as web pages, e-mails, or chat conversations. 
(Eriksson & Kovalainen 2008: 125 – 126.)  
 
The interviews as empirical data collection method can be structured or unstructured. 
According to Maylor & Blackmon (2005: 230 – 231), highly structured interviews can be 
characterized with closed questions where the interviewee need to answer all questions in the 
questionnaire in a structured manner, while in unstructured interviews the interviewees are 
asked open questions to discuss the topic on a general level and where the emergent concepts 
are included in the discussion during the interview.  
 
In a semi-structured interview, the discussion topics, and themes, as well as related questions 
are prepared before the interview takes place. In the interview, the interviewer is leading the 
discussion by asking the planned questions but is not limited to the questionnaire only. 
Instead, the interviewer is prepared to ask additional questions if the interviewee brings up a 
new relevant issue related to the research question. The semi-structured interviews are quite 
conversational and unformal, which requires paying attention so that all planned topics are 
covered in the interview. (Eriksson & Kovalainen 2008: 82.) According to Yin (2009: 69), 
the interviewer should have a firm grasp to the issues being investigated and be a good 
listener who is able to ask good questions and interpret the answers. To be able to plan 
relevant questions for the interviewees in this study, the characteristics of the planned Health 
Benefit Analysis tool was investigated in advance using the provided materials. Also, the 
concepts of individual and population health management, health benefit analysis, care gap 
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analysis, value-based healthcare, and big data analytics in healthcare context were studied. 
The interview questions were planned so that they help to find answers to the research 
questions. Also, the planned theoretical framework was considered when planning the 
interview questions, e.g. how big data analytics may affect the co-creation practices in the 
healthcare ecosystem and what the possible benefits for the defined stakeholders could be.  
 
Information gathering in discussions and meetings 
 
In this study, data has been retrieved first by preliminary discussions with the project sponsor 
and main developer as indicated in Table 5, and by gathering information from the provided 
project documentation as well as from other project specific source materials such as web 
pages. (Yin 2009: 101 – 103.) 
 
Table 5. Information gathering through preliminary discussions. 
 
 
Discussion  Organization Date Recorded / 
Notes taken 
Project Director,  
Human-Driven Health 
/ Senior Lead 
The Finnish 
Innovation Fund 
Sitra 
23.05.2017 
24.05.2017 
01.06.2017 
22.06.2017 
04.09.2017 
Notes taken 
Medical Doctor, Ph.D. / 
Editor-in-Chief / Original idea 
and main development of the 
HBA tool 
Duodecim Medical 
Publications Ltd. 
29.05.2017 Notes taken 
 
 
Conducting the interviews  
 
After the preliminary data was collected, a semi-structured interview was planned, and 
discussion themes and main questions formulated (Appendix 3). The questions include 
general orientation questions regarding the reasons for the development and interviewees role 
in the project, as well as detailed questions following the patterns of the selected theoretical 
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model of the study. In addition, some questions related to the possible challenges related case 
project or developed tool were included. (Yin 2009: 87, 106 – 109.) 
 
The interviews were conducted with eight interviewees representing the different 
organizations involved in the case project. Most of the questions were answered with long 
replies, but some of the questions were more challenging to answer and they had to be 
clarified, e.g. regarding the potential benefits, the interviewer clarified with statements which 
the interviewee accepted or rejected. The interviews were carried out online with Skype for 
Business and recorded. The recordings were transcribed into text format for analysis 
purposes. The interviewees are representatives of the Health Benefit Analysis tool 
development project parties and related experts. The time and duration of each interview is 
summarized in Table 6. 
 
Table 6. List of interviewees, time schedule and duration of interviews. 
 
 
Interviewee /  
Role in the project 
Organization Date of 
interview 
Duration 
 
Recorded / 
notes taken 
Senior Lead /  
Project Director 
The Finnish 
Innovation Fund 
Sitra / sponsor 
22.09.2017 65 min. Recorded 
Project Manager in the 
piloting health centers 
City of Helsinki / 
Selected health 
centers  
26.09.2017 48 min. Recorded 
Medical Doctor, Ph. D. 
/ Service Operator  
for Well-being /  
Senior Advisor 
The Finnish 
Innovation Fund 
Sitra 
26.09.2017 41 min. Recorded 
Medical Doctor, Ph.D. / 
Editor-in-Chief / 
Original idea and main 
development of the 
HBA tool 
Duodecim Medical 
Publications Ltd. and 
Health and Social 
Security Enterprise 
Saarikka 
27.09.2017 64 min. Recorded 
Research Principal 
Lecturer / Welfare 
Technology Expert 
Satakunta University 
of Applied Sciences 
27.09.2017 50 min. Recorded 
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Professor / 
Development Advisor  
Tampere University 
of Technology 
28.08.2017 49 min. Recorded 
Project Manager in the 
piloting health center 
Health and Social 
Security Enterprise 
Saarikka 
29.09.2017 62 min. Recorded 
Project Director / 
Self-care and  
Self-help Expert 
City of Espoo /  
ODA Project 
(Self Care and 
Digital Value 
Services) 
04.10.2017 50 min. Recorded 
 
Data analysis 
 
In qualitative research it is common that the distinction between data collection and data 
analysis is not clear, rather they are intertwined and closely related to each other. Likewise, 
in this study, ideas for classification and organizing interview data began to emerge already 
during the data collection and interview phases. (Eriksson & Kovalainen 2008: 299 – 300.) 
 
To analyze the collected empirical data, for this study the most suitable strategy is to rely on 
theoretical propositions as it helps to organize and focus on relevant data (Yin 2009: 130). 
Moreover, since the patterns and concepts of the theoretical model were already used as a 
starting point for designing the research questions, it is naturally clear that this will follow 
throughout the analysis process as well.  
 
In practice, the transcribed empirical data is first classified and organized anonymously, 
according to the same themes as used in the research questions which again are based on the 
BDET model. The answers of all interviewees are compiled and summarized thematically 
(Eriksson & Kovalainen 2008: 128), which after the data is analyzed by building an 
explanation about each theme. The themes used in the compilation are, in addition to the 
project scope and participants description, the big data analytic components and capabilities 
describing and explaining the HBA tool resources and characteristics of analytical level. 
Moreover, the value co-creation practice break-down and benefit dimensions with respective 
examples are used as themes in accordance with the BDET model. Classification of the 
empirical data according to these themes, enables the explanation of the phenomena in 
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narrative form. (Yin 2009: 141.) The analysis and explanations are written in the stated order 
and respectively supported with anonymous quotations from the interviews. Pattern 
matching, which according to Yin (2009: 136), in explanatory studies can indicate the 
dependencies between variables, is applied when indicating the paths-to-value chains, i.e. 
what kind of analytic capability leads through a specific value co-creation practice to a certain 
benefit that creates value. The paths-to-value chains are drafted last to summarize the analysis 
and provide answers to the research questions. 
 
 
3.4. Validity and reliability  
 
Validity of a case study can be tested with four tactics that are construct validity, internal 
validity, external validity, and reliability. Construct validity is ensured in this study with 
using multiple sources of evidence, i.e. several interviewees in the data collection phase and 
case project related documentation, and by having key informants to review the draft case 
study report to check that the context related information and other details regarding the case 
specific information is understood and reported factually correctly. (Yin 2009: 41 – 42.) 
Internal validity is mainly a concern for explanatory case studies where the researcher is 
trying to explain how and why an event led to another. Another concern regarding this tactic 
is the problem of making the right conclusions based on the evidence and reasoning. In this 
study the internal validity is aimed to be verified by using pattern matching and explanation 
building. (Yin 2009: 42 – 43.)  External validity deals with the problem of knowing whether 
the case study’s findings are generalizable. Typically, single case studies offer poor basis for 
generalizations (Yin 2009: 43) for the entire population. As this study is a qualitative single 
case study and unique in nature, it only aims at theoretical generalization.  
 
Reliability of a study means that the study procedures are documented to the extent, that if 
another researcher later conducts the same case study, the findings and conclusion should 
arrive at the same (Yin 2009: 45). The semi-structured interview questions, empirical data, 
references, and the applied theoretical model are well-documented and by that means the 
repeatability and reliability of this study are ensured. Reliability and transparency are also 
achieved by linking the analysis results with references to theory. 
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4. EMPIRICAL FINDINGS 
 
In this chapter, the studied case and its development project are presented. Also, the project 
participant organizations’ roles, and objectives for participating in the project, are introduced. 
In addition, some other organizations that carry out development closely related to the case 
project are also presented. Their representatives have been interviewed in this study in order 
to gain better understanding on the studied topic and being able to find more versatile answers 
to the research questions. Thereafter, the empirical findings are presented according to the 
selected theoretical model and discussed so that first, the basic features of the Health Benefit 
Analysis (HBA) tool, as well as its resources and capabilities, are described, followed by 
presenting its changing effects on value co-creations practices. Moreover, the impact of 
introducing advanced analytics to the healthcare ecosystem, and its effects on value co-
creation actors are indicated and discussed. Finally, the discovered potential benefits and 
performed value for the selected stakeholders are presented.  
 
 
4.1. Case: The Health Benefit Analysis tool  
 
The case, the HBA tool, is developed and implemented to conduct health benefit analyses as 
described in subsection 2.1.1. and presented in Figure 9. The purpose of the HBA tool is to 
analyze combined sources of patient data to provide a list of net impacts of different 
interventions. For an individual patient, a health impact can be considered a benefit or a harm. 
On population level, the HBA tool helps the healthcare service providers to allocate resources 
for medical services and interventions by listing how many people would benefit from each 
intervention complemented by numbers that indicate the average health impact of each 
intervention. 
 
The HBA tool development project 
 
The HBA tool development project is introduced based on pre-discussions with the 
development project director and the main developer of the HBA tool. Also, information 
provided on Sitra’s (2016) website, and other related materials are used. The role of each 
participant organization and the relation of the additional organizations to the HBA tool and 
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the development project, are also complemented with information provided by the respective 
interviewees. 
 
The development project’s official name is “Health Benefit Analysis, From Quality Data to 
Effectiveness project”. The Finnish Innovation Fund, Sitra, is the sponsor of the project. The 
project was initiated in September 2016 and it will run until the end of 2018. Sitra’s partners 
in the project are Duodecim Medical Publications Ltd., City of Helsinki, and the health and 
social security enterprise Saarikka, which consists of the municipalities of Kannonkoski, 
Karstula, Kivijärvi and Kyyjärvi and the City of Saarijärvi. (Sitra 2016.) Other organizations 
having related projects in the subject matter area are Satakunta University of Applied 
Sciences (SAMK) and Tampere University of Technology (TUT), which are developing an 
educational program for health analysts, professional experts in conducting and interpreting 
the health analytics and acting as advisors in healthcare and social welfare services, and City 
of Espoo, which is running the ODA project developing self-care and digital value services 
for citizens. These organizations are participating or related to the development of HBA tool 
as follows: 
 
Sitra, the project owner, is funding the development of the HBA algorithm, program code, 
and the pilot testing of the tool. Among the reasons for supporting the development of the 
HBA tool is its value promise according to which the HBA tool provides support in decision-
making for the healthcare professionals, as well as offers the service users new ways to assess 
their health status. (Sitra 2016.) Also, in near future, according to the ongoing healthcare 
reform in Finland, the healthcare services are organized by counties which would benefit of 
using the HBA tool when planning and implementing the healthcare services on upper levels 
of the healthcare ecosystem. Moreover, it can be stated that Finland is a propitious country 
to develop this kind of tool, because several useful data sources already exist, which, in 
future, combined with the data collected from the personal wellness equipment of individuals 
constitute the big data repository for the analyzing purposes. In addition, this digital medical 
intelligence combined with the knowledge that the structures of Finnish society enjoy its 
citizens’ trust are the ingredients for developing a successful product, even for international 
export. (Sitra 2016.) In practice, Sitra is also having an advisory role in the project, as it is 
supporting the development work with its own expertise regarding the digitization of social 
welfare and healthcare services.  
 64 
 
 
Duodecim Medical Publications Ltd., a company owned by The Finnish Medical Society 
Duodecim, is the main developer of the HBA tool. The society has over hundred years, since 
its establishment in 1881, been developing the professional skills and clinical practice of 
doctors through continuous education, publications, and grants. Duodecim Medical 
Publications Ltd. publishes content intended for healthcare professionals as study materials 
and to support their daily work, e.g. evidence-based medicine guidelines, evidence-based 
medicine electronic decision support system (EBMeDS3), and Current care guidelines4. 
(Duodecim 2017.) Moreover, since Duodecim has over the years produced medical 
information for healthcare professionals and citizens, first in form of magazines and books, 
and then via electronic information portals, it is now broadening its services into new 
integrated information systems, such as the HBA tool which, in practice, is built on the 
EBMeDS.  
 
The City of Helsinki, is participating in the HBA tool development project as a pilot user and 
a contributor of the development of desired functionality of the tool. The tool is piloted in 
two health centers in Helsinki, which in this study represent healthcare service providers 
(Figure 1). In these health centers, the electronic health records are used for the analysis 
purposes, and the health benefit analyses are conducted with selected individual patients 
when they visit the health center at the doctor’s or other health professional’s reception. The 
City of Helsinki is participating in this project since it is aiming at reducing the health and 
wellbeing inequalities among citizens, as well as improving the productivity, effectiveness, 
and accessibility of healthcare services. The HBA tool is useful for that purpose.  
 
The Health and Social Security Enterprise Saarikka, is also participating in the HBA tool 
development project as a pilot user and contributor to the development of the tool. In this 
study, also Saarikka represents a healthcare service provider (Figure 1). In Saarikka, the tool 
is piloted more widely, as the health benefit analyses are planned to be carried out as a virtual 
health assessment for the whole population of Saarikka. By conducting this kind of virtual 
health assessment, it is possible to find the patients’ hidden needs for interventions. The 
intention is to invite the discovered high-risk patients to visit the healthcare professionals 
according to their individual needs. In this project, Saarikka is also aiming at developing its 
                                                 
3EBMeDS, Computerized clinical decision support rules: 
https://www.duodecim.fi/english/products/ebmeds/ 
4Current care guidelines: https://www.duodecim.fi/english/products/current-care-guidelines/ 
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practices regarding the recording of patient records. In addition, Saarikka expects that the 
results of this project will help with planning the future development of healthcare services. 
 
The Satakunta University of Applied Sciences (SAMK) and the Tampere University of 
Technology (TUT), are currently developing and carrying out the first educational program 
intended to train health analysts. This is a new profession in the field of healthcare and 
wellbeing. The trained health analyst professionals are planned to use the HBA and other 
analytical tools, interpret, explain, and discuss the results and possible interventions with 
patients. In practice, the training program is conducted in cooperation with local county 
healthcare service organizer and service providers such as regional and central hospitals.    
 
The ODA, Self Care and Digital Value Services project5 is one of the key projects in the field 
of health and wellbeing set by the Finnish Government Programme6. The project is led by 
the City of Espoo but implemented simultaneously in several Finnish hospital districts and 
cities, e.g. in Helsinki, Tampere, Lahti, Turku, Oulu and Hämeenlinna. The ODA is planned 
to be in use throughout Finland in 2018. The plan is, that the development carried out in the 
ODA project later enables the integration of the patients’ self-measured health data in the 
data sources of the HBA tool, which will enrich further the analytics results generated by the 
tool (cf. Appendix 2: 15).  
 
In the following subsections, all required big data components and analytical capabilities, 
value co-creation practices, potential benefits and created value are studied and analyzed 
using the applied BDET model (Figure 8) introduced in subsection 2.4.2. as a framework. 
 
 
4.2. Health Benefit Analysis tool explanatory variables 
 
To successfully achieve the potential benefits and create value with the HBA tool, a set of 
explanatory variables are needed. As a starting point, a qualified patient data repository and 
specific rules for filtering the patient data are required. The HBA tool is planned to collect 
                                                 
5 About ODA project, in Finnish: https://www.kuntaliitto.fi/sites/default/files/media/file/ODA-
esite.pdf  
6 Implementation of the Government Programme: http://valtioneuvosto.fi/en/implementation-of-the-
government-programme 
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and combine data from several different sources, and with an algorithm developed for the 
purpose analyze and provide support for healthcare professionals in decision-making, e.g. 
which interventions should be made, and in which order the interventions should be 
implemented. In practice, the HBA tool is embedded as an additional feature in the EHR 
system interface. Health centers in Helsinki and Saarikka currently use the Pegasos EHR 
system, which contains all patient’s data mainly in structured format, provided that the health 
professionals using the system have managed to enter the data in the system correctly and 
according to the standardized and pre-defined structure, which also enables more feasible 
individual care planning (cf. Health Level Seven International: 2013). Having correct patient 
data in the correct format in the EHR system is the pre-requisite for successful and valid 
results of the analytics.   
 
4.2.1. Big data analytics components 
 
The big data analytics resources of the HBA tool consist of several architectural components, 
that are the patient data repository, for example the Pegasos EHR and personal health records 
retrieved from My Kanta7 as planned in the ODA project. In future, it is possible that data 
repositories include biobanks and genome databases, too. Evidence and guidelines are based 
on the EBMeDS rule set, based e.g. on systematic reviews provided among others by 
Cochrane8. Currently, the patient data used for analysis is in a structured and coded format. 
The HBA tool does not process any unstructured or semi-structured data at this point. As the 
volume of the data is already large and growing, and the velocity of generating new data in 
the system is increasing, as well as the variety of the data is becoming more versatile, it can 
be claimed that the definition of big data is fulfilled (cf. Berman 2014: xx).  
 
The analysis itself is conducted by EBMeDS’ rules engine and risk calculators, which are 
algorithms that for example, examine the data and analyses whether a person belongs to a 
certain patient group, does the patient have a certain disease, and does he or she have a risk, 
which indicate a need for medication, picks up these patients from the database and suggests 
intervening with specific medication. The HBA tool resources, functionality, and outputs are 
                                                 
7 My Kanta, provided by Kela, is a nationwide patient data repository which offers citizens the 
opportunity of examining and managing their own medical records. http://www.kanta.fi/en/ 
8 Cochrane is an international network providing systematic reviews on evidence from research to 
enhance healthcare knowledge and decision-making. http://www.cochrane.org/ 
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described in detail in Figure 9. There are three outputs that are illustrated with 1) green dots 
that indicate interventions the patient in question has received and is eligible to, 2) red dots 
that indicate identified care gaps reported as decision support reminders suggesting 
interventions, and 3) blue dots that indicate the health impact of each intervention in the 
whole population. Basically, Figure 9 illustrates also how the health benefit analyses are 
described in subsection 2.1.1. 
 
 
 
 
 
 
Figure 9. Resources, functionality, and outputs of the Health Benefit Analysis tool 
(Kunnamo 2017).  
 
The results generated with the HBA tool are currently presented in form of tables (cf. 
Appendix 1), that are the data interpretation components. For example, a table presenting a 
real-time report on the individual patient’s condition and suggested interventions ranked by 
numerical values indicating the potential benefit of the respective intervention. Another 
 68 
 
 
example of data interpretation component is the table (cf. Appendix 1) consisting of an 
analysis of health impact of a specific drug for individual patients, who can decide and rank 
their personal importance of listed health outcomes, both benefits and harms from the drug, 
and better understand the balance of benefits and harms. A third example is the data 
interpretation component that provides information on benefits from filling a care gap in a 
population, that in turn provides meaningful business insights and operational key 
performance indicators for healthcare service organizers and providers. (cf. Wang et al. 2017: 
2 – 3, 6.) However, according to some interviewees, the interpretation of the data could be 
made more user-friendly by developing the visualization of the results, for example instead 
of the tables and figures only, present the information also in graphical form that is easier for 
the users, especially the patients, to understand. 
 
4.2.2. Big data analytics capabilities 
 
The analytical capabilities of the HBA tool can be understood differently depending on the 
viewpoint. The interviewees' views on the analytical capabilities of the tool vary between the 
characteristics of descriptive analytics, i.e. business intelligence and different levels of 
advanced analytics. This is understandable, because the practical experiences of using the 
tool are still very limited, and the perceptions of the capabilities are based on theoretical 
conceptions and testing the demo version of the tool. It is expected, that the actual state of 
the capabilities in terms of the level of analytics are clarified to the users during the pilot use 
of the tool. Therefore, in this study, the analytical capabilities of the tool are presented and 
discussed solely based on the perceptions of the interviewees.  
 
The analytics generated with the HBA tool can be considered being on a descriptive level 
when it is evaluated according to the fact that it is based on data describing what has happened 
in the past. Although the patient records stored in the EHR system are real-time or near-real 
time, they are already the past when the analysis is performed. However, it is a matter of 
professionals to ensure that the patient data used for analysis purposes is fresh enough to be 
valid for decision-making support or business intelligence. The analytics is considered to 
represent a descriptive level of analytics due to the following statements: 
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“It shows the current situation by using the information that is being entered to the system, 
for example what is the patient's condition now and whether all the treatments are correct, 
or if something is missing.” 
 
“The tool that is now being developed is actually beneficial to all players in the sense that it 
provides this kind of health information to our superiors and managers, and quality 
information regarding on what kind of care level our customers are, and what we should do 
to improve it. It helps to plan and develop training, for example, and then on the other hand, 
there are other benefits as well, when customers benefit from receiving an informed analysis 
of their own health.” 
   
The HBA tool can be claimed to perform predictive level analytics when it investigates data 
and extrapolates a forecast about what is likely to occur, i.e. which health risks might realize. 
This can be indicated with the following statements regarding the predictive analytics 
capabilities: 
 
“It utilizes existing algorithms such as the Finnriski algorithm based on large research data 
from the National Institute for Health and Welfare and the National Public Health Institute 
to assess how high a person's risk is, for example during the next 10 years, to get a 
myocardial infarction or stroke, or how high the risk is that he gets ill with diabetes when he 
knows his risk factor, his waistline, his length and weight, his history, so it can be estimated 
how high a risk is that he or she will become diabetic. Such risk assessments have been built 
into the tool.” 
 
“The health benefit analysis number itself is already looking to the future in that sense, that 
it tells, when specific diagnosis and interventions are used, what the expected risks of the 
outcomes are. In a way, it is comparing the outcomes of different interventions, and what is 
the probability of a specific health benefit for patients with different interventions.” 
 
“Yeah, it's now quite predictive, it's already using some types of calculators, they're found to 
be good and they work right there, so that's right in that sense.” 
 
“It gives some predictions as it comes to the risks, but it does not pose a management plan 
or risk assessment for the future, that it is a matter of other tools.” 
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However, as some interviewees think, the ranked list of recommended interventions provided 
as a result from the health benefit analysis of an individual patient, is considered to guide the 
decision on what should be done, and which interventions and in which order would best 
improve the health outcome for the patient. As the interventions are recommendations, the 
patients may, however, choose differently. Also, the results of the health benefit analysis on 
population level provides the healthcare service providers insights e.g. on how to develop the 
services and what interventions are offered to whom, so that they are best suited to the needs 
of the population base. Therefore, as these statements indicate, the analytics capability can 
be considered being on a prescriptive level as well: 
 
“Yeah, there may be a recommendation that if the customer is for example overweight and 
smokes and has certain risks, that rational treatment for him would be weight control or 
smoking cessation, and then we can think about how to arrange interventions.” 
 
“In my opinion, the greatest added value is that you can give priority to certain things, for 
example, if you are not ready to do this (smoking cessation) and it does not matter that you 
will suffer in the event of a complication because you do not consider the importance of this 
procedure, but you can adapt to it.” 
 
“At the population level, when the health benefits of different people are combined –  their 
net benefits – we can see what it is worth to invest in, how we can prevent specific events, or 
how many such and such patients should we treat to be able to prevent one event.” 
 
As indicated above, the levels of performed analytics can be overlapping, i.e. descriptive 
analytics and business intelligence complemented with features of advanced predictive and 
prescriptive analytics. Moreover, regarding the analytical capability of the HBA tool, it can 
be stated that it analyzes big data with varying levels of analytics, without ruling out each 
other. (cf. Delen 2014: 16.) 
 
It is also evident, that the HBA tool does not, at least at the moment, have any characteristics 
or features related to artificial intelligence, machine learning or deep learning, e.g. natural 
language-processing or other learning abilities:  
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“This is not a machine learning system because it does not itself learn how to operate. 
Instead, this is based on rules and effectiveness figures that are derived from systematic 
reviews and applied here. It cannot be called an artificial intelligence either, but rather a 
rule-based system that, based on these rules, applies this knowledge. Artificial intelligence 
is characterized by the fact that it actually learns, that is to say, in a way, analyzing what 
happened to the persons and then changing its reasoning algorithm itself, without any person 
altering it. Here, this is not the case.” 
 
However, when the HBA tool is developed further, and additional, even more complex 
algorithms and data sources are added to the system, it is possible to reach the analytics levels 
that are achieved when employing artificial intelligence and machine learning. 
 
“That is the further development, as long as we first get these first algorithms done, then in 
the future, it will probably be possible to combine artificial intelligence to it, if we want to 
study bigger masses. Thinking about the population health perspective, people with the same 
health factors, and when looking for some of the reasons, and as more information starts to 
come, it would be just natural to associate it with some artificial intelligence that can mine 
bigger masses of data.” 
 
The statement above, is related also to traceability, as it refers to data-mining with virtual 
health checks in order to harvest people having the same health factors, or same patient 
characteristics and conditions. Traceability is needed when e.g. the health center is aiming to 
develop the care of specific patient groups: 
  
“It is at least now the goal that we could look at for example children with overweight and 
see what kind of program we could do for them, or provide alternative anticoagulant therapy 
for those who are not in balance or who are least balanced on warfarin, and that we could 
see if a change in medication for those people is needed.”  
 
4.2.3. Summary of explanatory variables 
 
In summary, it is evident that the HBA tool fulfills the basic requirements for conducting 
advanced analytics of healthcare big data. The access to structured qualified patient data is 
available, as well as evidence-based rules, calculators and rules engine for filtering and 
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analyzing the data. The desired output; prescriptive ranked interventions both for individual 
care planning and population health management are achieved, as well as business 
intelligence reports for healthcare service provider’s workflow management and resource 
planning are available. 
 
Moreover, resources such as fact-based decision-making organization culture, committed 
management and personnel with advanced analytical skills are among the key success factors 
when conducting big data analytics. Regarding the HBA tool development and piloting, these 
critical factors are fulfilled. This argument is supported by the clear business need Sitra has 
identified when deciding to fund the project, the long history that Duodecim has with 
developing digital decision-support services, the commitment from Saarikka and City of 
Helsinki in the piloting and development, as well as the fact that SAMK and TUT are already 
educating new professionals with the needed skills to conduct and interpret health analytics. 
Spreading the data-driven culture also to the citizens by providing them a possibility to enter 
their self-measured data for analysis purposes, and engaging them in decision-making on 
their own care, are strong signs of the new data-driven culture and digital transformation in 
the society. (cf. Delen 2014: 240.) 
 
The perceptions of the analytical capabilities are varying among the interviewees. The 
descriptive level is achieved when the results are used for evaluating the patient’s current 
condition based on what is stated in the patient’s health records. The importance of entering 
the data and ensuring its correctness, is emphasized. Also, the usefulness of descriptive level 
results for the managerial purposes, e.g. quality development, is recognized. Predictive level 
analytics can be claimed to be achieved when the results are perceived to provide insight to 
potential health risks, or when the analysis compares the expected outcomes of alternative 
interventions. Finally, prescriptive level analytics can be claimed when it is possible to give 
priority to specific interventions, or when it is possible to see what is worth to invest in 
population health, for example to prevent a specific event of a disease.  
 
The characteristics of the explanatory variables are expected to affect the value co-creation 
practices and potential benefits, which are analyzed and discussed in the following 
subchapters. 
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4.3. Affected or transformed value co-creation practices  
 
In this subsection, the anticipated impacts of using the HBA tool in value co-creation 
practices, and expected involved actors related to respective example are presented and 
discussed. The results indicate, with practical examples, how the current value co-creation 
practices are expected to be affected or reshaped after implementing big data analytics as an 
actor to the healthcare ecosystem. Compared to the examples of the practices presented in 
the BDET model (Table 3), it can be stated that the empirical data contains some similarities, 
but also introduces completely new, HBA tool specific practices in the value co-creation. A 
summary of the affected value co-creation practices is presented in Table 7.   
 
 
Table 7. Value co-creation practice sub-elements affected by using the HBA tool. 
 
 
Value  
co-creation 
practice 
Example of affected sub-element  
 
Expected 
involved actors 
Meaningful 
use of EHRs  
Ensure that correct patient data needed for the 
analysis purposes are entered into the EHR 
system in structured format 
 
Achieve a comprehensive and up-to-date view on 
the patient's health in order to provide the right 
care 
 
Act proactively based on virtual health checks of 
the population, and invite patients in need to visit 
health center for further examination, individual 
care planning and treatment 
 
Trace and find undertreated and overtreated 
patients, as well as useless treatments or 
medications 
 
Detect specific trends and behavior related to 
population health 
Health professionals 
 
 
 
Health professionals 
 
 
 
Health professionals 
 
 
 
 
Health professionals 
 
 
 
Health professionals 
Healthcare managers 
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Evidence-
based 
medicine 
Explore the facts from medical events or patient 
treatments to improve specific outcome 
 
Build holistic view of evidence by insights from 
literature-based data and research studies, such as 
EBMeDS and Current care guidelines 
 
Select together with the patient the most suitable 
intervention from the evidence-based ranked list 
Health professionals 
 
 
Health professionals 
 
 
 
Health professionals 
Patients 
Multi- 
disciplinary 
cooperation 
Improve the care planning and care process of 
multimorbid patients  
 
 
Provide joint decisions regarding treatments to 
patients from a multidisciplinary team 
Care managers 
Hospitalists 
Social workers 
 
Care managers 
Hospitalists 
Clinical 
resource 
integration 
Allocate health service (monetary) resources as 
indicated by population needs  
 
Allocate health service resources to reduce 
indicated care gaps in selected patient groups 
 
Self-evaluate the need for health service or 
intervention with the provided analytical tools 
and platforms 
Healthcare service 
organizers  
 
Healthcare service 
providers  
 
Patients or their 
custodians  
Network 
collaboration 
Create cross-boundary practices 
 
Lower the threshold of raising patient issues  
and facilitate discussion and decision-making 
between professionals and stakeholders 
 
Build a common understanding of provided 
healthcare services and needed interventions  
 
Prioritize interventions between specialties  
Health professionals 
Social workers 
Schools  
Associations 
Patients or their 
custodians 
 
 
 
Health professionals 
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Network 
knowledge 
creation 
Share knowledge about service guidance across 
sector boundaries 
 
Collect all data in one place for centralized 
information sharing and analysis purposes 
 
Learn which interventions the patients value and 
prefer  
Health professionals 
Social workers 
 
Health professionals, 
e.g. Health analysts  
 
Health professionals 
Patients 
Personalized 
care 
Create personalized disease risk profile and 
integrated care management plan for each patient 
 
 
Make shared decisions on interventions 
proactively  
 
Influence in own care by evaluating and 
choosing between recommended interventions 
Health professionals 
e.g. Hospitalists or 
Care managers  
 
Health professionals 
Patients 
 
Patients 
 
 
As indicated with several detailed examples, each value co-creation practice is affected due 
to involvement of the HBA tool. The evolutionary-level value co-creation practices (cf. 
Wang et al. 2017: 2 – 3) such as meaningful use of EHRs require paying attention to ensuring 
the quality and format of the patient data and evidence-based medicine and the timeliness of 
the evidence enabling the accuracy of the analysis results. The tool also enables completely 
new practices such as virtual health checks and tracing patients with hidden needs, which 
aims to narrowing the indicated care gap. Additionally, the tool enhances internal integration 
as it enables more effective multidisciplinary collaboration in mutual care planning and 
decision making.  
 
Regarding the revolutionary-level value co-creation practices, (cf. Wang et al. 2017: 2 – 3), 
business process redesign is indicated in form of clinical resource integration which is 
affected by the HBA tool as it enables improvement in allocation of healthcare resources and 
targeting the monetary resources to interventions which are proved the be most beneficial on 
the population health level. Business process redesign is in question also when individual 
patients learn to practice self-evaluation and self-care before contacting health centers. That 
in turn provides an opportunity to target the healthcare resources for those who benefit more 
from it. Moreover, business network redesign is indicated in value co-creation practices 
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regarding network cooperation and knowledge creation. They are affected by the HBA tool 
as it is expected to enable to improve, and even create new, cross-boundary collaboration 
methods both in creating and compilating patient information, as well as sharing it for cross-
boundary planning and decision-making.  
 
The most game-changing revolutionary-level value co-creation practices which lead to 
business scope redefinition are related to the personalized care. The HBA tool enables 
making accurate personalized care plans based on a patient’s disease risk profiles. It also 
creates completely new practices, where the patient becomes an important actor and essential 
value co-creator. The tool provides an opportunity to a major change in the current practices 
where health professionals, especially doctors are solely responsible for decision making and 
risk bearing regarding the selected interventions and health outcomes (cf. McGuire et al. 
1988: 39; Jung & Padman 2015: 302). These value co-creation practices are changing the 
current set up between the health professionals, especially doctors, and patients. The health 
benefit analysis offers the patient an opportunity to evaluate the health benefits or harms of 
the recommended interventions and freedom to make an informed choice between them.  
 
The indicated examples of respective value co-creation practices are analyzed and discussed 
in more detail in the following subsections. 
 
4.3.1. Meaningful use of electronic health records 
 
Patient health data has traditionally been entered and stored in electronic health records and 
databases, which are continuously fed with new data, and which ultimately are left unused. 
The stored data has not been considered useful until the patient gets ill and next time visits 
the health center or hospital, where the doctor then checks what kind of health issues the 
patient has suffered from before.  Now, with the HBA tool, the use of the EHRs is expected 
to become more meaningful as the patient data is used, together with decision support 
systems, in a more proactive manner, which is expected to be useful for several stakeholders. 
However, to get valid results, it is essential that the patient data is without unnecessary delays 
recorded into the EHR system in a structured format. This directly affects the value co-
creation practice as there now is a managerial need to plan and agree between professionals 
about who and how to deal with this requirement. (cf. Sivarajah et al. 2017: 265.) The 
following statement supports this: 
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“First of all, it is important to have correct information in correct format in the EHR system, 
which, however, may mean additional work, e.g. blood pressure, smoking habits, medication 
and diagnostic information (e.g. coronary artery disease) must be up to date.” 
 
Because the EHR system is now expected to contain more and correct information about the 
patient, the HBA tool enables achieving comprehensive and up to date view about patient’s 
health and improves the possibility to provide correct treatment: 
 
“After that, the doctor can get an overall picture of the patient. He can get suggestions for 
decision support on how to treat the patient. He also can see the health benefit analysis, from 
which he can see which interventions would most benefit this patient, as well as which might 
be less beneficial for him.” 
 
It is often the case, that patients have hidden needs for a treatment or that they may benefit 
from having a specific medication. These needs may be discovered only randomly when a 
patient visits a doctor for another reason. Therefore, virtual health checks conducted with the 
HBA tool on EHR records of a selected population in order to find patients potentially in 
need for treatment of medication, are changing the current reactive practices into more 
proactive value co-creation practices, where the tool generates lists of patients by specific 
conditions. The list can help in tracing the undertreated patients, as well as possibly 
overtreated patients, and by that means reduce the indicated health care gaps. (cf. Wang et 
al. 2017: 7.) The following statement describes this practice as follows: 
 
“We are talking about proactive activity, for example, when a person has been exposed to 
health risks, a professional may take the initiative and contact this person to discuss whether 
he or she would be willing to visit the reception or start some treatments. So, preventive 
action instead of waiting for someone to reserve time from the reception.” 
 
“It helps to find undertreated patients, but also those who are overtreated. There may be 
some medication or treatment that the patient uses unnecessarily, or there may be such 
treatments that this patient should not use at all, but instead should use something else. So 
that kind of insight can be obtained from EHR.” 
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The HBA tool also enables the detection of specific health and behavioral aspects of the 
population from the EHR system, which has not been possible earlier because of lack of data 
or useful summaries. Now, decent summaries that are enabled by the health benefit analysis 
conducted on the population level can support in decision-making aiming to reduce health 
inequalities, for example in the development of specific health services in the area:  
 
“We currently do not get any data right out of our systems. We have only a vast collection of 
information about our clients, levels of care and diagnosis, but no decent summaries”, and 
further “the HBA tool can open up the vision, once we get better data and we see e.g. that 
smoking in some areas is higher than in other areas, so it might be worth to invest more in 
smoking cessation interventions there, than in another area.” 
 
As recording and analyzing the data means work, in future, this could be the task of the health 
analysts. They could be responsible for collecting and analyzing the EHR data and providing 
the results for e.g. prioritizing and rationalizing the operations. However, they need a 
mandate to use the data and overall, be part of the care team.  
 
4.3.2. Evidence-based medicine 
 
Evidence-based medicine is already practiced in health centers that now are piloting the HBA 
tool. They have experience with Current care guidelines and EBMeDS, which both are built 
on wide medical evidence such as Cochrane reviews, meta-data-analyses, latest research, and 
literature. According to the current practices, the evidence-based support systems may, for 
example, provide an automatic notification about medical incidents, where the doctor needs 
to pay attention to something critical regarding the patient’s medication. Health professionals 
can also get feasible insights and recommendations from these systems without specifically 
asking for it, as indicated in the following statement: 
 
“Currently, the decision support means that even without anyone actively searching 
information, it automatically displays messages, and suggestions on how to treat the 
patient.” 
 
The health benefit analysis algorithm is designed to use the evidence in these systems and 
combine it with the patient data retrieved from the EHR. The objective is, that the tool 
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provides a user-friendly view to the patient’s health and suggested evidence-based 
interventions. It generates, unlike the current systems, a ranked list of the most suitable 
interventions for the individual patient to choose from, and by that means enables new ways 
to health professionals for co-creation of value with the patients. In future, when the tool is 
developed further, some interviewees expressed their wish that amount of data further 
increases and that also some artificial intelligence related features could be developed, 
perhaps a common system for the whole country. 
 
“Decision support notifications have been more fragmented listings, and they have not 
evaluated separately what might be the most useful intervention. In that sense, of course, the 
evidence-based medicine is increasing, and the tool makes it easier to use.” 
 
“Of course, the artificial intelligence is as good as the data mass that it has at its disposal. 
If we could get all the information for common use, that would be great.” 
 
However, it is expected that the relation between the health professionals, specifically the 
doctor, and the patient, needs to be clarified in terms of what is really the mandate of the 
patient to choose an intervention he or she prefers. For example, it should be decided whether 
the patient is allowed to choose the most expensive intervention, even it is not ranked to bring 
the best health outcome, or how should the interventions be chosen if the patient is not 
mentally mature enough to take this decision. What kind of value co-creation practice would 
suit best for this kind of situation need to be planned and taken into use, as expressed in the 
following statement: 
 
“One has to think about what is happening when a patient wants, for example, a very 
expensive intervention, but the benefit of which is estimated to be reasonably small in that 
situation. Then one also must think if a professional can refuse to give you any intervention, 
just say that okay sorry, but you are not given that treatment now. It is a bit too expensive for 
you to get it. This is probably the biggest challenge. Transparency is a good thing, but are 
both professionals and customers willing to receive new stuff?” 
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4.3.3. Multidisciplinary cooperation 
 
Multidisciplinary cooperation is traditionally coordinated in health centers by work pairs 
consisting of a patient's personal doctor and personal nurse. In future, there could be a new 
role, a specific care manager, who is responsible for the holistic planning and coordinating 
of an individual patient’s care. So far, there has been a lack of tools for this and it has 
therefore been hard to maintain individual care plans, but this is about to change. (cf. 
Batalden et al. 2016: 509.) Moreover, the HBA tool is seen useful when there is a need for 
flexibility, e.g. when planning interventions for multimorbid patients, such as the elderly 
having many parallel health problems. Also, in cases where there are many service providers 
and actors involved in the care, e.g. from the social sector, or associations, it helps when there 
is a tool that is able to provide a comprehensive view of the patient’s situation. 
 
“The HBA tool is also used when certain patients, such as substance abuse and mental health 
patients, need flexible operating models. There are also many different actors involved in the 
care of the elderly, and families with children. In a way, this tool gives a common medical 
aspect that everyone can take advantage of and get a similar perspective on the patient.” 
 
In hospitals it may be more complex, since each medical doctor consults only on his own 
area of medical specialty. It is anticipated, that a new doctor specialist role, so called 
hospitalist, are soon introduced to the Finnish hospitals. Having hospitalists is already quite 
common in the US hospitals. They are generalists, who manage the overall treatment of the 
patients, and when needed, request a consultation from the doctors representing the other 
narrow medicine specialties. The HBA tool would be perfect in that sense, as the hospitalists 
could use it for conducting health benefit analyses and plan and coordinate the patient’s care 
process in the hospital, as indicated in the following statement: 
 
“Of course, their job involves then conducting the health benefit analysis and thinking about 
which of those special medical care would be important to this patient. It is a tool that anyone 
can use, regardless of the specialty. The results of a health benefit analysis are 
understandable in such way that a representative of any specialty or professional group can 
take advantage of the results.” 
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The multidisciplinary cooperation and joint decision-making between specialties in hospitals, 
including social factors, can be improved significantly with the HBA tool and the new roles 
of care managers and hospitalists. Health analysts could also have a role here in future. 
However, it is evident, that only introducing new tools and systems is not enough, but also 
the related roles and processes, for value co-creation, need to be addressed.  
 
4.3.4. Clinical resource integration 
 
Using advanced analytics provides good insights on planning resource allocation in 
healthcare services, both for the healthcare service providers and for the healthcare service 
organizers, operating on macro and meso levels in the healthcare ecosystem (cf. Frow et. al 
2016: 27). As these actors seek to reduce inequalities in the population and to narrow health 
care gaps, the HBA tool is useful as it helps to indicate and analyze the needs of the specific 
patient groups within the population and at a proper allocation of health care resources. 
 
A good practical example on this is the need for reducing the smoking habits of a specific 
group, as the health center management can get insight on the issue for planning how and 
with which resources it is most effective to intervene the situation: 
 
“Individuals who would benefit significantly from tobacco weaning are searched from the 
population. Then tobacco weaning is organized to everyone wishing for it. In this way, we 
try to identify the resource needs, for example what resources and what interventions should 
be made. When identifying how many customers need this intervention, we can calculate how 
much of the nursing staff’s work time need to be allocated to the provision of tobacco 
weaning services.” 
 
If the implemented intervention is successful, it is possible to indicate with the HBA tool its 
impact on the health outcome of this specific population. In this way, the healthcare service 
providers and organizers can get feedback on the success of the intervention they invested 
resources in. In addition, it provides insight and information on rationalization of operations 
and further development of resources. Moreover, when an individual or group of patients 
succeed to stop smoking, the potential health outcome is shared with the healthcare service 
providers as they now can allocate resources for other patient groups. 
 
 82 
 
 
Also, as the healthcare service customers are seen as active actors of value co-creation, it 
would in future be desirable that they, before contacting health centers, conduct a self-
evaluation of their current need for health service and intervention using the provided 
analytical tools and platforms for the purpose. Only in case there is a health problem, which 
requires a specific intervention, the patient is offered an appointment at the health center. In 
this way, it can be claimed that patients contribute to more effective resource allocation of 
healthcare services. 
 
4.3.5. Network collaboration 
 
It is anticipated that using the HBA tool across the health and social sector boundaries would 
be a very good improvement in the current siloed operations but requires paying attention to 
legal matters and regulations on the higher levels of the ecosystem (cf. Frow et al. 2016: 27). 
The multisectoral cross-boundary network cooperation (cf. Triple Aim, Kindig & Isham 
2014: 3) would benefit all actors in value co-creation and be more cost-effective, but the 
current practices evidently need to be transformed, and new ones created with careful 
planning, ensuring that the legal aspects are fulfilled, and citizens’ privacy treated in a most 
cautious manner. This concern comes up the following statement: 
 
“If healthcare is difficult, social work is even more difficult because there are so many 
legislative obstacles making it so siloed and hierarchical, that there are even bigger 
problems than on the healthcare side. So, there is room for development and it would be quite 
brilliant if such tools were used to change the operating model. It is of course regrettable 
that for example child protection issues are really difficult. That is why legislation is 
understandable and somehow seems impossible to reform, if some lawyers say something. 
But if we get their understanding, then we have to make that change.” 
 
The use of the HBA tool enables also the lowering of the threshold of raising patient issues 
and facilitates discussion and decision-making between professionals, for example between 
doctors and nurses, and between health professionals and representatives of the social sector, 
e.g. social or home care workers: 
 
“It facilitates cooperation between the professional groups as I have discussed for example 
with the home care workers. It works as a tool giving them the opportunity to have a better 
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conversation with the doctors. Now home nurses can more confidently propose for example 
some changes in medication or treatments that they have found necessary. Before, it was 
more like a gut feeling, but now the tool provides a little more robust approach to the nurses 
to present their opinion. They can now be more confident to point out which are the health 
benefits, and whether a drug needs to be exchanged, or what should be done.” 
 
In the care-cycle of one patient, there might be many health professionals involved, as well 
as professionals from social or school sectors. Family members also have an important role 
if the patient is a child, or another, often older, family member suffering from multiple 
diseases. However, since the patient is the starting point of the care, and set in the focus of 
the health service, it is important that all actors in the network can build a common 
understanding of the provided healthcare service and needed interventions. This is brought 
up in the following statement: 
 
“In network cooperation, the issue has been resolved so that the patient is at the center of 
the activity. The information is personalized and targeted to that person, including any risk 
factors. That is, of course, better than having the information scattered in different places.” 
 
With the help of the health benefit analysis results and integrated care planning it is possible 
to prioritize the needed interventions and decide the order in which interventions should be 
carried out so that the recovery of the patient is as smooth as possible, and the health 
outcomes are successful (cf. Porter 2010: 2478; Nordgren 2009: 124). For example, if an 
elderly patient needs geriatric rehabilitation and several major interventions from different 
specialties, e.g. a hip surgery and a cataract surgery at the same time, it is essential, that the 
network cooperation between the specialties is working smoothly, as expressed here: 
 
“For example, an ophthalmologist orders a patient to cataract surgery. However, the patient 
is also in queue for hip surgery and at the same time waits for a geriatric rehabilitation 
period somewhere. Now, it is worthwhile to prioritize and plan carefully whether the cataract 
surgery is reasonable before the rehabilitation period, or before the hip surgery. This is 
important in order to prevent the risk that with poor vision ability the patient may run into 
thresholds and crash.”   
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4.3.6. Network knowledge creation 
 
The current plan is to include in the health benefit analysis some variables from the social 
side as well e.g. information on a patient’s employment status, area of residence, need for 
social services and other relevant social factors. Adding these variables to the analysis 
provides a possibility for more accurate results regarding the recommended interventions, 
which again lead to additional benefits and even better health outcomes. Therefore, the HBA 
tool will enable sharing knowledge about a patient’s service guidance across sector 
boundaries (cf. Kindig & Isham 2014: 3): 
 
“Of course, one would like it to become a tool for social work as well. That would work just 
fine if we get some variables from the social side as well, then it could work on that side too.” 
 
“Yes, for example, in a service guidance unit that defines which unit takes the responsibility 
of further care of the patient. In the service guidance unit there is a wide range of experts in 
the field, who in that sense try to build a picture of both the social care and the health care 
needs of the patient. In that sense, this brings one more tool to them as well.” 
 
Most of the patient data is currently scattered which makes it difficult to gain a 
comprehensive view on a patient’s status. The HBA tool can motivate the actors to organize 
this better by collecting all data in one place for centralized information sharing and analysis 
purposes (cf. Health Level Seven 2013: 6 – 7). For the time being, this is a task that could be 
carried out e.g. by the health analysts: 
 
“A health analyst could make a patient summary, meaning that they would collect the 
information from where they are now scattered and this tool (HBA) would be one part of it. 
That is, this kind of health benefit analysis would be one thing, and then there could also be 
some medical images so that the whole summary is ready, i.e. what treatments have been 
made and what allergies the patient has. I believe doctors might think it would be beneficial 
as they would get a summary, so that they do not have to first open ten different computer 
programs to get the information.” 
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Using the HBA tool and conducting health benefit analysis, and discussing the results with 
the patients enables discovering new knowledge regarding the patient’s preferable 
interventions: 
 
“Yes, it is likely that new information will be formed, at least as to how the patient himself 
evaluates the health benefits and the side effects of different therapeutic methods on his 
health and well-being. That is, we get information on at least patients' attitudes and 
opinions.” 
 
Practices where new actors, such as health analysts, and additional information from other 
sectors are introduced, require, however, a change in the current approach in the relationship 
between the doctors or other health professionals and the patient. Also, discussing more 
openly about the optional interventions with the patients means that the healthcare services 
may become more accessible than before (cf. Nordgren 2009: 121). 
 
4.3.7. Personalized care  
 
Traditionally, a patient has been treated with interventions ordered or recommended by 
doctors or other health professionals. Moreover, the doctors have been responsible for the 
decision-making and risk-bearing for what kind of care and which interventions a patient is 
offered (cf. McGuire et. al 1988: 39, 46, 48). Personalized care, in turn, is more patient-
centered practice where the patients themselves are involved in the care process. One of the 
key features of the HBA tool is, that it supports the integrated personalized care practices by 
providing insight to the most beneficial interventions.  
 
In order to be able to recommend the most suitable interventions and achieve the best possible 
health outcomes for a patient, health professionals need to know, among other things, the 
disease risk profile of the patient. Therefore, the doctor determines the baseline risk of the 
patient (cf. Appendix 1). When the baseline risk is known, the HBA tool enables achieving 
more accurate and personalized disease risk profiles of the individual patients. This practice 
also produces valuable information for integrated care planning for each individual patient. 
In future, it is, however, needed and expected that additional risk calculators as well as e.g. 
genome data are added to the tool, which enables analyzing even a broader disease spectrum 
and gives a possibility to enhance the personalized care even more. It can be concluded, that 
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the current practices regarding personalized care are in progress of continuous improvement 
as the HBA tool is developed further with additional algorithms and data sources:   
 
“We need a lot of information about the patient's risk level, for example what is the patient's 
baseline risk. We already have risk calculators, but we need a lot more. That is, we should 
find the best prognostic evaluation tools and algorithms in the world and utilize them.” 
 
“I think it (personalized care) will improve, but it is not entirely clear what kind of 
information it can be based on. In particular, if genetic data is added at some point, it 
certainly means a personal approach.” 
 
The results of the performed health benefit analyses provide a good basis for discussion 
between health professionals and patients how to act proactively in order to ensure the best 
possible health outcomes for the patient. Moreover, the evidence-based discussion enables 
shared decision-making regarding the interventions. The result of the analysis and discussing 
it with the health professional, provides patients the opportunity to influence in their own 
care by choosing between recommended interventions. (cf. Batalden et al. 2016: 509) These 
value co-creation practices are indicated for example in the following statements: 
 
“When a customer can rate and value evidence-based interventions themselves, one can start 
implementing an intervention that he or she is motivated to accept and that he / she sees 
relevant, for example smoking cessation or something else. With this tool, you can quite 
concretely show the effect of the smoking cessation, or if we give this and that medicine, it 
will have that effect. It is, in fact, something more tangible.” 
 
“The tool calculates the benefits and harms, for example, if I as a patient decide that I do not 
want this medicine because it has these side effects, it calculates the benefits in relation to 
the harms.” 
 
“This is a crucially important issue for personalized care, for example, when talking about 
self-care in long-term illnesses, I personally see that the customer is one of the actors of 
production, one of our resources that implements and influences the effectiveness of 
professionals. So, in that sense it is extremely important.” 
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Being able to provide such information and decision power to the patients is new and 
innovative (cf. Jung & Padman 2015: 302). It is expected that when the HBA tool is 
developed further, it can provide evidence-based recommendations on interventions to 
patients having different diseases and involve them in value co-creation, and that is even 
more revolutionary. It is also anticipated that the tool will encourage the health professionals 
to act more proactively and use it more actively in care planning.  
 
4.3.8. Effects in healthcare ecosystem actors 
 
Introducing the HBA tool, or more specifically the algorithms it employs, to the healthcare 
ecosystem effects not only the value co-creation practices but means also changes in the 
responsibilities of the existing staff, as well as creates a need for completely new roles and 
professions. It can be claimed, that this is an exemplification of how digitalization and data-
driven culture changes the traditional organization, professions, and practices on all levels. 
Utilizing advanced analytics in healthcare requires competence development of the 
healthcare professionals and their management, as well as professionals closely involved in 
the care cycle, such as social workers. For example, to get the best possible results and health 
outcomes with the HBA tool, the professionals need to understand the importance of 
structured patient data, learn how to produce, and store it correctly, they need to have skills 
to conduct the health benefit analysis, interpret the results and facilitate the discussion with 
the patients. However, conducting the health benefit analyses with the tool, does not require 
any specific technical or mathematical skills, but it helps if the user understands the basics 
of statistical methods and is able to explain how the results are generated, i.e. why a result is 
what it is. The healthcare managers and actors on the upper levels of the healthcare ecosystem 
need to understand what the implementation of such tools and advanced analytics requires 
from their side, i.e. commitment to the data-driven solutions and selected tools, and alignment 
with business and IT strategies (cf. Delen 2014: 240). 
 
The mentioned new roles in the healthcare service provider organizations are hospitalists, 
care managers, and health analysts. Hospitalists are doctors taking the overall responsibility 
of the specialized medical care process of a patient in hospitals, which is already a common 
practice e.g. in the US. Care manager, in turn, is a new role which can be carried out also by 
current health professionals. A care manager can be for example a nurse who is responsible 
for coordinating the patient’s care and care planning in a health center, and possibly across 
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sector boundaries. A completely new profession is the so-called health analyst, intended to 
act as a professional conducting health analytics, interpreting the results, as well as explaining 
and discussing the results with the patients. To educate health analysts, SAMK in Finland 
and Tallinn University of Technology in Estonia have initiated a pilot program training health 
and social care professionals with various backgrounds to become health analysts. Most of 
the health analyst students are currently working in health centers, hospitals or in social sector 
in different roles, so they are in a key position when introducing this new profession to the 
organizations, and to the patients.  
 
Patients are also considered to be part of the healthcare ecosystem on the micro level (cf. 
Frow et al. 2016: 27). Now, when moving towards data-driven culture and using the HBA 
tool to improve the personalized care through health benefit analyses, the role of the patient 
becomes more active as they are given the chance to evaluate and choose which intervention 
they are ready to take (cf. the personalized care in the previous subsection). If the chosen 
intervention is for example smoking cessation or weight control, it means that the patient has 
a crucial role in value co-creation in order to achieve the desired outcome. Using the tool or 
understanding advanced analytics is not a requirement for the patient but committing to the 
chosen intervention is. 
 
 
4.4. Potential benefits and performance 
 
The potential benefits achieved by conducting health benefit analyses with the HBA tool are 
studied through examples falling into operational, managerial, strategic, organizational and 
IT infrastructure benefit dimensions. The potential benefits revealed in the interviews are 
further categorized into performance that generate value for individual patients, value for 
population health, and business value for healthcare service providers or organizers. The 
identified expected benefits of respective dimensions, and their value generated to the 
determined stakeholders are summarized in Table 8.  
 
Compared to the benefit dimensions and examples of subdimensions presented in the applied 
BDET model (Table 4), the empirical data verifies a number of operational, managerial, 
strategic, and organizational benefits generating value for the healthcare service provider. 
However, due to the nature of the HBA tool, most of the suggested IT infrastructure benefits 
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are not realized. Moreover, due to the fact that the BDET model was complemented with 
individual patients and population health, some additional benefits and value generated for 
these stakeholders, are identified.  
 
Table 8. Expected potential benefits and performance that generate value to stakeholders. 
 
 
Benefit 
dimensions 
Indicated expected benefits Value generated to 
Operational 
benefits  
Improved workflow efficiency 
Productivity improvement 
Cost reduction  
Improved and accelerated use of information 
Quality monitoring 
Target treatments to those who benefit most 
Accuracy of clinical decisions 
Improved health outcomes 
Active participation in own care 
Influence in selected interventions 
Improved customer experience 
 
 
 
Healthcare service 
provider 
 
Population health 
 
 
Individual patient 
Managerial benefits Improved care planning and decision-making 
Improved performance 
Improved allocation of resources 
Business intelligence 
Improve direction and management of staff 
Improve employee satisfaction 
Reduce health inequalities in the population 
Narrow the discovered care gaps  
Prevent cases of overtreatment 
 
 
 
Healthcare service 
provider / organizer 
 
 
Population health 
Individual patient 
Strategic benefits Facilitate discussion among decision makers 
Gain comprehensive view for meeting future 
needs 
Contribute shift to value-based healthcare  
Implement the selected vision and maintain 
focus 
Build competitive advantages 
Build new business innovations and alliances 
 
 
 
Healthcare service 
provider / organizer 
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Organizational 
benefits 
Improve team work 
Cross-functional communication 
Solve multidisciplinary problems quickly 
Organizational learning from clinical reports 
Process and quality development 
Learn to know the patients better 
Ensure seamless patient experience 
 
 
Healthcare service 
provider 
 
 
Individual patient 
IT Infrastructure 
benefits 
Better use of existing healthcare 
information systems, e.g. supplement EHR 
Improved information gathering and sharing 
between actors with extended access rights 
Healthcare service 
provider 
 
Individual patient 
 
4.4.1. Identified benefits 
 
In each benefit dimension there are some specific expected benefits which are presented and 
discussed in more detail in the following paragraphs. Several of the reported potential 
benefits have been revealed already in the answers regarding value co-creation practices, and 
some are identified through presenting statements to the interviewees. 
 
Operational benefits  
 
It is revealed, that with the HBA tool it is possible for the healthcare service provider to 
obtain several operational benefits, such as improved workflow efficiency and productivity, 
as well as cost savings. All these are mainly achieved through the proactive approach to the 
integrated care planning and interventions because it is more effective to treat patients before 
they get more severely ill. The HBA tool also enables accelerated use of population health 
data and clinical information which further improves productivity of the operations and the 
effectiveness of health outcomes. (cf. Nordgren 2009: 124.) Further, it enables improved 
operational quality monitoring, which so far has not been possible to this extent. It also 
contributes to the quality and accuracy of clinical decisions. Both quality monitoring and 
accuracy of clinical decisions are considered significant core issues in health benefit analyses. 
These statements confirm the mentioned operational benefits: 
 
“It is a benefit, if care operations can be rationalized and arranged according to the needs.” 
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“The tool makes you also ponder internal processes and avoid possible bottlenecks.” 
 
“Quality monitoring, and the accuracy and quality of care decisions are essential core 
issues, and there is lot of room for improvement.” 
 
“As the tool enables patient data analysis even once a month, it is possible to plan and 
implement any quality improvement measures and monitor their effectiveness.” 
 
Quality monitoring is achieved through the tool-based metrics and controls, as well as quality 
benchmarking between care units. Additional operational benefits can be generated through 
health benefit analyses in order to provide insights on how to target interventions and 
treatments to those who benefit the most, which is beneficial from the population health point 
of view. It also helps with finding new views on potential treatments and personalized patient 
care. Customer experience is improved as patients now are considered active actors in value 
co-creation, e.g. using the HBA tool enables more personalized care practices and it increases 
transparency as the patient is offered a chance to choose between interventions and 
participate in shared decision-making. (cf. Payne et al. 2008: 93 – 94.) This is expected to be 
valuable to the patient and lead to increased customer satisfaction. (cf. Batalden et al. 2016: 
509.) The following statement sums up the operational benefits regarding the customer 
experience: 
 
“The ability to influence your own care will definitely bring a better service experience.” 
 
Moreover, access to the operational benefits is supported by the easiness of using the existing 
knowledge and applying evidence-based care with the tool. 
 
Managerial benefits 
 
The HBA tool is expected to generate managerial benefits to the healthcare service provider, 
e.g. in providing information and views on planning and resource allocation, which again 
improves performance. It can also act as a tool for prioritizing health care resources for 
producing the needed services for those who benefit the most from them, and that generates 
value for the individual patients and population health. It that sense, the health benefit 
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analyses can be considered business intelligence, that gives the management information on, 
what kind of health services are needed in the population in order to reduce the health 
inequalities and discovered health deficits. (cf. Airoldi et al. 2014: 970; Kunnamo 2016: 69.)  
 
“The tool gives background information about the population base to whom services are 
produced, it is a kind of business intelligence.” 
 
Another expected managerial benefit is related to the direction and management of staff and 
improved employee satisfaction. These benefits can be achieved as the HBA tool enables the 
leading doctors to direct and guide their subordinates in their work and to facilitate the value 
co-creation between health professionals and patients. Moreover, the tool is expected to 
improve employee satisfaction, as the healthcare professionals can gain more meaningfulness 
in their work since they now can find the right evidence-based interventions that are predicted 
to work for the respective patients, and which are proved to be beneficial: 
 
“This is also meaningful for employees because they are now better able to find interventions 
that are useful to patients.” 
 
Strategic benefits 
 
Implementing and using the HBA tool provide several strategic benefits for healthcare 
service providers, such as public or private health centers and hospitals, but also for the 
healthcare service organizers that are operating on the upper levels of the healthcare 
ecosystem. These actors are the state health authorities such as local provinces responsible 
for steering public funding and organizing the healthcare services. For example, the health 
benefit analysis performed on population level, can facilitate discussion among decision 
makers e.g. regarding the future development and organizational planning of health services 
in order to reduce health inequalities among population. Moreover, in case the healthcare 
service organizer’s or provider’s strategy is targeting to shift to value-based healthcare (cf. 
Cosgrove 2013; Porter & Teisberg 2006), the HBA tool can provide valuable insights for 
reaching that goal as well. To implement the selected vision and maintaining the focus, for 
example preventive care can be supported with the HBA tool as it offers evidence-based 
insights into proactive care and interventions. The following statement describes the 
intentions to shifting into more value-based measures: 
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“It is expected, that it can be agreed with the decision makers regarding the current service 
descriptions, which now are based on quite quantitative measures, that they are 
complemented with measures of effectiveness.” 
 
The HBA tool contributes to achieving business competitive advantages by using advanced 
analytics and business intelligence as a differentiator. When people are offered the freedom 
to choose where they want to consume their health services, it is obvious that the possibility 
of personalized care planning and optional interventions are expected to attract patients to 
acquire health services from a health center that can guarantee better health outcomes by 
providing health benefit analyses, and proves it has the latest health technology solutions at 
its disposal. This ensures accessibility to qualified health services for the customers of the 
smaller health service provides as well. The HBA tool with its evidence-based analytics is an 
important differentiator for gaining competitive advantage especially for small health centers 
which compete against bigger health service providers employing a greater number of 
qualified healthcare experts, and therefore gaining competitive advantages: 
 
“I think that if you have the latest technology, it is a kind of competitive advantage, especially 
for a small health center. It means access to a big data mass, which is a great thing.” 
 
The HBA tool, especially when more new knowledge is gained on the effectiveness of the 
interventions, enables building also new innovations (cf. Groves et al. 2013: 7): 
 
“The tool provides a starting point in which we have information about the effectiveness of 
interventions and what is important. On this basis, it is good to build new operating models, 
practices, and tools.” 
 
The innovations can be new operating models and practices related e.g. in the patients’ 
freedom of choice, or new tools that can be built in cooperation or in strategic alliances with 
other public and private healthcare actors.   
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Organizational benefits 
 
It is indicated, that using the HBA tool generates numerous organizational benefits as well. 
It is revealed that it can improve team work and cross-functional communication, especially 
when e.g. a health analyst is available to facilitate the cooperation. Also, multidisciplinary 
problem solving is supported when doctors use the results generated with HBA tool at their 
meetings to plan how they can achieve the desired effectiveness and set goals. Organizational 
learning can be achieved for example when the analytics and statistical knowledge regarding 
patients and population is being used as business intelligence for process development and 
quality improvement. The tool enables and supports the development of specific quality 
metrics for the purpose. Moreover, it can be claimed, that organizational learning also 
happens when health professionals teach each other and learn to know their patients and their 
healthcare service needs better, which in turn leads to improved patient experience. (cf. 
Demirkan et al. 2015: 734.) The following statement indicates how the introduction of the 
HBA tool has kicked off organizational learning process: 
 
“Yes, this has already kicked off a lot of discussion and dialogue and ideas about how people 
in their own work and in their own workplace could act as an organization. For example, 
doctors have planned how they could train each other and what kind of support system has 
been built for them.” 
 
IT Infrastructure benefits 
 
The HBA tool is built in as an additional new feature in the existing EHR systems, so it 
supplements rather than replaces or adds on other IT systems. Therefore, it is not relevant to 
expect it to generate any specific cost-related benefits either at this point. It enables, however, 
a chance to improved information sharing between the health centers and hospitals, as well 
as with patients, provided that the access rights to the health benefit analysis results are 
granted (cf. Appendix 2: 1). The following was stated regarding the IT infrastructure benefits: 
 
“This is a complementary system that does not replace anything. In a way it enhances the 
use of existing systems.” 
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“I do not think it affects IT costs. Most probably it has an impact on treatment costs once we 
get the right patients in the right place at an earlier stage.” 
 
4.4.2. Value generated to stakeholders 
 
Based on the discovered benefits discussed above, it can be stated that the value promise of 
the HBA tool and performed advanced analytics arise value for the stakeholders as follows: 
 
Business value for the healthcare service providers and at some cases additionally for the 
service organizers arise through all benefit dimensions. Value is prominent in strategic issues, 
such as in gaining competitive advantage through differentiation, support for additional 
innovations, and in contributing the shift into value-based healthcare (cf. Porter & Teisberg 
2006:8; Cosgrove 2013) where the definitions of value is based on the betterment of the 
patient’s health (cf. Rantala & Karjaluoto 2016: 34). In addition, utilizing the business 
intelligence generated by the tool in high-level strategic decision making and long-range 
planning, create business value for the managerial, operational, and organizational activities. 
Moreover, as there are no significant benefits regarding the IT infrastructure, the business 
value of the HBA tool can still be considered positive, as it acts as a complementary system 
that helps to get more out of the existing systems.  
 
The value generated for individual patients can be specified as the value-in-use (cf. Vargo et 
al. 2008: 146; Grönroos 2008: 298, 304), that arise especially due to the significant new 
modes of interaction. In such interaction the digital actor, i.e. the health benefit algorithm, 
and the patient are considered being part of the health ecosystem (cf. Frow et al. (2016: 27), 
and therefore active actors in value co-creation. (cf. Rantala & Karjaluoto 2016: 40.)  
 
The value for the individual patients can also be claimed due to the freedom of making 
informed choices among recommended and ranked interventions, as well as transparency in 
seeing the possible care paths, and shared decision-making (cf. Nordgren 2011: 309). This is 
different from the traditional care practices where the health professionals and doctors have 
been in the position to decide what treatments are recommended in the first place, and which 
services patients are eligible to.  
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Moreover, due to the possibility of conducting virtual health checks in the population, the 
individual patients can achieve value as they are proactively found and invited to further 
health examination and offered needed health services. This means that individual patients 
can avoid undertreatment by getting accurate and evidence-based diagnosis earlier and the 
needed interventions in good time, compared to the situation where they seek help only after 
getting more severely ill.   
 
The value generated for the individual patients is expected to improve even more when the 
analyzed big data is added with the patients’ self-monitored data gathered e.g. from various 
wearable devices or genome databases (cf. Demirkan et al. 2015: 735; Sakr & Elgammal 
2016: 50). The wider range of data enables receiving more specific information about the 
possibility of getting a particular disease. It also enhances the patient's awareness of 
belonging to a certain risk group and gaining understanding on how own decisions effect in 
own care in practice. Moreover, it may even reduce the false perceptions among patients 
regarding the effectiveness of specific interventions (cf. Frow et al. 2016: 24, 26). 
 
In order to achieve the stated value, individual patients are expected to provide honest 
information about themselves and their health. Health professionals should take into account 
that people tend to embellish the information regarding their lifestyle habits, for example 
smoking habits, which may lead to incorrect health benefit analysis result, and therefore lead 
to unsuitable recommendations of interventions. It is assumed, that most people are interested 
in their own health and willing to take responsibility in own health care by committing to the 
recommended interventions. Therefore, mutual trust is also needed. It is, however, possible 
that some people do not see value in this and completely refuse to have their personal health 
benefits analyzed. This should be respected as sharing own health data is voluntary, and it is 
also possible that people are not mature to assimilate this kind of information. 
 
With the above said, it can be concluded that health benefit analysis performed with the tool, 
generate value for the individual patients according to the customer service logic (cf. 
Grönroos 2008: 298) and in accordance with the five axioms presented in the latest research 
regarding S-D logic (cf. Vargo et al. 2008: 148; Vargo & Lusch 2017: 47; Lusch et al 2016: 
2957). 
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Value for the population health is generated by reduced health inequalities, and by providing 
more cost-effective and better health services to the right people who need and benefit the 
most from them. Better targeting also prevents the use of healthcare resources in cases where 
no intervention or action is required. Moreover, value is generated when identifying regional 
health risks and developing health services to reduce those risks. (cf. Kindig & Stoddart 2003: 
381; Kindig 2007: 143; Airoldi et al. 2014: 970; Kunnamo 2016: 69.) 
 
In addition, it is revealed that value for the population can be achieved through the new and 
more feasible cross-boundary co-creation practices between healthcare and social sectors. 
With the tool it is possible to get a high amount of information and knowledge on population 
health, and possible to learn what kind of actions are needed, or not needed in a specific 
region or patient group. Common priorities and together ensured accessibility to the relevant 
health services and educated health professionals is valuable for the population, and the 
whole society. Further, other actors in the ecosystem such as peer support groups and related 
patient associations are considered to build value for the population health. It is also expected, 
in case it would be possible to reduce the bureaucracy and share more information between 
the sectors, that there are even more possibilities to develop completely new and value 
creating services for the population. Altogether, these above-mentioned value-creating 
factors, and the expected reduction in cost per capita of healthcare, generate value for the 
population health. (cf. Triple aim, Kinding & Isham 2014: 3). 
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5. CONCLUSIONS 
 
In the latest era of digital disruption, new service platforms, advanced analytics and artificial 
intelligence are introduced in healthcare at increasingly fast pace. The potential benefits and 
value of advanced analytics of healthcare big data cannot be denied. The value promise 
presented in public discussion and proved in the research conducted so far, indicate the great 
potential that analytics have to improve the current value co-creation practices and generate 
better health outcomes for the individual patients as well as for the population health. The 
more versatile, larger, and higher-quality data resources that are used for the analytics, the 
more accurate results and better health outcomes can be achieved. The HBA tool uses, now, 
in the implementation phase structured patient data and evidence-based medical information 
for the analysis. The plan is to, in the future, increase the data volume, variety, and velocity, 
as well as number of algorithms and features of machine learning systems to predict the 
relative effects and duration of effects of the interventions. These developments provide 
further improved support for the health professionals in gaining even more accurate results 
based on the latest research and up-to-date data.   
 
  
5.1. Key findings 
 
The key findings of this study can be described with answering to the research questions and 
indicating the identified challenges and opportunities revealed during the research process. 
The answers are provided and discussed in the following paragraphs. 
 
Indicated paths-to-value chains 
 
The first research question on how does big data and advanced analytics generate potential 
benefits and value for healthcare service providers, individual patients, and population 
health, can be answered with the indicated paths-to-value chains, illustrated in Figure 10. 
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Figure 10. The most evident identified paths-to-value chains (illustration adapted from Wang 
et al. 2017: 10). 
 
The first path-to-value chain describes how big data analytics, i.e. health benefit analysis 
generates value through the data interpretation component consisting of visual reports that 
support and enable better facilitation of mutual decision-making. That, in turn, affects 
personalized care practices by transforming it into a more interactive process between the 
doctor, other health professionals and the individual patient. This arises both operational and 
managerial benefits that further generate value for all stakeholders. Business value is 
generated for the healthcare service provider through improved quality, workflow efficiency, 
care planning and decision-making procedures that can lead to cost reduction and better 
performance. The business intelligence gained through health benefit analyses is also 
valuable for managing resource allocation and improvement of personnel management and 
employee satisfaction. Further, it can be claimed, that the better patient experience achieved 
by personalized care, generate business value, too. This path-to-value chain provides value 
for the individual patient by offering the possibility to become an active actor in his/her own 
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healthcare. The possibility to influence one’s own care by choosing between interventions 
and participating in shared decision-making to greater extent than before, can be claimed to 
lead to better patient experience. Value for the population health is generated when the 
operational and managerial benefits gained through the health benefit analysis reports 
support to target treatments to those who benefit the most from them, which consequently 
leads to reduced health inequalities. 
 
The second path-to-value chain of the health benefit analysis generates value for the 
stakeholders through data aggregation which refers to the versatile combination of data 
sources and algorithms enabling traceability of e.g. patients with a specific condition. 
Further, this makes more accurate evidence-based decision making possible and the use of 
EHR more meaningful as the patient data is not only stored, but also used for analysis 
purposes. The achieved benefits are mainly operational enabled by improved and accelerated 
use of information and data. The business value on this path is achieved mainly through 
improved productivity due to increased data utilization rates. The improved health outcomes 
enabled by more accurate clinical decisions can be claimed to generate value for the 
individual patients. On the population health level, the value of health benefits analysis arises 
from the possibility of conducting virtual health checks for the specific populations. 
 
The third path-to-value chain is identified based on the analytical capability of the health 
benefit analysis, that is, depending on the viewpoint, advanced predictive analytics when it 
is used in evidence-based medicine to generate ranked lists on the recommended 
interventions and their possible health outcomes for the individual patients. Better predictive 
analytics, in form of individualized estimation of baseline risks, makes the quantitative 
estimation of value (net health benefit) more accurate. Moreover, optimized treatment 
choices on the individual level, value-maximizing and equal resource allocation on the 
population level, and patient-centered care on the care provider level are all promoted. (cf. 
Airoldi et al. 2014: 970; Kunnamo 2016: 69.)  
 
Analytical capability can also be considered business intelligence when the results are used 
for the benefit of operational, organizational, and strategic functions. Benefits are achieved 
through the improvements in clinical resource integration and network collaboration and 
knowledge creation practices, as well as better coordinated multidisciplinary cooperation. 
The improvements in these activities in turn create value for the individual patients in form 
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of evidence-based medicine practice and recommendations of interventions, as well as 
seamless patient experience. The level of the health benefit analysis’ analytical capability 
provides business value and competitive advantage for the healthcare service providers as it 
acts as differentiator separating it from other service providers. Being able to present such 
value propositions to the patients, is also a source of business value. 
 
Potential benefits 
 
The empirical data verifies several operational, managerial, strategic, and organizational 
benefits generating value for the healthcare service provider. However, due to the nature of 
the HBA tool, most of the suggested IT infrastructure benefits are not realized. (cf. Shang & 
Sheddon 2002: 277; Wang et al. 2017: 3; Wang & Hajli 2017: 290, 293). Business value is 
prominent in strategic issues, such as in gaining competitive advantage through 
differentiation, support for additional innovations, and in contributing the shift into value-
based healthcare (cf. Porter & Teisberg 2006:8; Cosgrove 2013), where the definitions of 
value is based on the betterment of the patient’s health (cf. Rantala & Karjaluoto 2016: 34). 
 
Value co-creation practices and healthcare ecosystem actors 
 
Regarding the supportive research question, how does big data and advanced analytics affect 
the value co-creation practices and actors in a healthcare ecosystem, it can be stated that 
employing advanced analytics affects, to varying extent, the examined value co-creation 
practices identified in the literature (cf. Wang et al. 2017: 7; Frow et al. 2016: 31 – 33). The 
meaningful use of EHRs is affected mainly due to new requirements related to the structured 
patient data recording practices, and by providing possibilities to detecting specific trends 
and behavior related to population health, as well as conducting virtual health checks. 
Evidence-based medicine practices are affected as it is now possible to gain better real-time 
insights based on medical events and treatments regarding individual patient’s health. 
Multidisciplinary cooperation and clinical resource allocation practices are enhanced with 
the insights generated from the health benefit analyses, which were not available before. 
Network collaboration and network knowledge creation practices are affected, because new 
cross-boundary cooperation modes are needed in order to build common understanding on 
patients, i.e. what is needed and how to prioritize. Finally, the personalized care practices are 
expected to be affected with a revolutionary transformation as the new value co-creation 
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practice denotes business scope redefinition in the way how patients are now integrated as 
actors in their own healthcare practice (cf. Nordgren 2009: 121; Wang et al. 2017: 2 – 3, 7; 
Payne et al. 2008: 93 – 94). 
 
The evolving co-creation practices set requirements for the healthcare ecosystem actors as 
well as they need to conform to new ways of working with patients and other actors that are 
professionals from other sectors and levels of the ecosystem (cf. Frow et al. 2016: 27). 
Moreover, new skills are needed related to structured recording of patient data and 
personalized care planning. In addition, there is a need for completely new competencies, 
especially regarding conducting health analytics and interpreting results, which can be 
fulfilled by, and training, completely new professionals, that are health analysts. It is also 
expected that new roles for doctors and other health professionals, such as hospitalists and 
care managers, are introduced. 
 
Identified challenges 
 
However, there are identified challenges to consider. There are for example ethical issues to 
address as the freedom to choose between interventions may lead to less effective choices in 
terms of health outcomes or costs. Sometimes it is even possible that patients are not mentally 
mature enough to take such decisions. There might also be some attitudinal challenges due 
to the changes in the value co-creation practices increasing the influence and decision power 
of the patients. Moreover, regarding privacy issues, the health professionals and service 
providers need to be cautious, in order not to breach any rules or regulations (cf. Delen 2014: 
9). For example, the good intentions to practice preventive care with population level health 
benefit analyses, and proactively contacting patients who have been identified to be in need 
for specific interventions, can be troublesome from the privacy regulatory point of view. In 
some cases, this is not a problem and patients are mainly satisfied and happy that they are 
offered the needed care in good time. But when taking another view, where a health center 
is approaching citizens who are not already patients having an active customer relationship 
with the inviting health center, the invitation might be interpreted as breach of privacy.   
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Opportunities 
 
There are yet many opportunities available to healthcare service providers using the HBA 
tool. They can develop even more new innovations and disrupting services in the field of 
healthcare. This, however, requires courage, and willingness to accept that there will be new 
professions and actors in the health ecosystem. There are opportunities for professional 
development as information technology and analytical skills are increasingly needed to meet 
the requirements set by preventive care practices and the demand for health coaching services 
among health service consumers and patients. Opportunities for innovation and development 
are created also for the educators of health professionals, as they are in key position when 
transferring the knowledge, practices and working culture to the future health professionals. 
  
Since knowledge regarding health issues is increasing among population, and as it is evident 
that people have access to constantly developing analytical tools, they have the opportunity 
to make better choices regarding their lifestyle. Further, the transfer into more personalized 
care practices in the healthcare services provides the opportunity to patients to be in a central 
role in the value co-creation of their own health outcome. Due to this and the fact that the 
value co-creation practices become increasingly data-driven, it can be claimed that the 
business scope redesign is on a disruptive and revolutionary level. (cf. Wang et al. 2017: 2 – 
3, 7). In the population health management, the opportunity to identify the potential care gaps 
among population contribute to achieving reduced health inequalities (cf. Airoldi et al.2014: 
970). 
 
 
5.2. Theoretical implications 
 
The theoretical implications of this study are manifold. First, the study contributes to filling 
the identified research gap regarding the business value of big data analytics in healthcare. 
This case study provides insight in how big data, i.e. structured patient data and evidence-
based medical information, is used for advanced analytics purposes in Finnish healthcare 
setting.  
 
The second theoretical implication arises from the need to extend the theoretical model which 
is used as a framework to examine the value for multiple stakeholders, that are healthcare 
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service providers, individual patients, and population health. In practice, the big data 
analytics-enabled transformation model (Wang et al. 2017) which studies the big data 
analytics solely from the business value perspective, is complemented with viewpoints of 
value for individual patients and population health. These stakeholders are added to the study 
and theoretical model because it is important to understand also the individual patient’s 
perspective in order to be able to develop the personalized patient centric care and motivate 
the patients to participate and acquire a more active role in their own care planning and shared 
decision-making. Regarding the population health perspective, it is essential to understand 
the generated value because it provides insights on how healthcare services should be 
targeted to close the indicated care gaps, which further supports the desired shift into value-
based healthcare. 
 
The third theoretical implication is to provide further understanding of the studied practices. 
The original theoretical model is concentrated on the examined practices from their IT-
enablement perspective, while in this study they are examined from the value co-creation 
perspective.  
 
With the stated modifications in the theoretical model, it is possible to examine the impacts 
of introducing health benefit analysis and the tool for conducting it and evaluate the desired 
value for respective stakeholders. When conducting a study on big data analytics, it is also 
essential to understand the distinction between the characteristics of business intelligence, 
advanced analytics, artificial intelligence and beyond. 
 
This study also reveals the theoretical implications regarding the need to revise the traditional 
views on actors in value co-creation. This is due to the fact that in addition to the human 
actors in value co-creation, also new digital actors, such as algorithms are becoming an 
essential part of the healthcare ecosystem. Introducing the data-driven practices in value 
creation and ecosystems is a disruptive change, which can be even considered to cause a 
paradigm shift (cf. Groves et al. 2013: 7; Lusch et al. 2016: 2960; Rantala & Karjaluoto 2016: 
40).  
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5.3. Managerial implications 
 
Managerial implications of this study raise firstly the importance and criticality of the 
commitment and support from management when introducing big data analytics as suggested 
in theory (cf. Delen 2014: 240 – 241) and as revealed in the analysis of the empirical data of 
this study. The management needs to ensure that the efforts are aligned with the business 
strategy and information technology environment and that the quality of data supports the 
implementation advanced analytics. Moreover, management needs to allocate enough 
resources, such as budget, time, and professionals like project manager, developers, subject 
matter experts, and other project workers in the project. As this project is carried out in 
healthcare, it is important to involve health professionals’ in the development and give weight 
to their views because for example nurses, doctors and other health specialists can provide 
valuable input to the development of the tools and related processes. In addition, data privacy, 
security, governance, and ethical aspects are managerial challenges which need to be 
considered when implementing advanced analytics in the field of healthcare (cf. Sivarajah 
et. al 2017: 265).  
 
Management needs also to consider that when a new tool that impacts and changes the status 
quo on many levels in the health ecosystem is introduced, it is important that it is properly 
integrated to the processes and that it becomes a natural part of the systematic way of 
working. It should also be remembered that the new analytical tool is not working by itself, 
but it needs management’s attention to ensure that also the health professionals commit to 
using it. It also needs to be ensured that the overall health service design supports the evolved 
value co-creation practices, especially regarding the personalized care practice and 
visualization of the reports so that the results can be interpreted without misunderstandings.  
 
It can also be concluded that there is an evident need to clarify and raise awareness of the 
HBA tool’s value promise for communication to the public (cf. European Union 2016: 55), 
as well as for commercialization to the domestic and international markets. In addition to the 
benefits and proposed value to the stakeholders, the level of current analytical capabilities 
and changes and requirements regarding the value co-creation practices should be explained 
to the desired target audiences. 
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5.4. Suggestions for future research  
 
As this study concentrates on the expected benefits and impacts in value co-creation practices 
from the developers’ and pilot users’ point of view, it would be of interest to conduct a 
follow-up study after a while to learn how the benefits and effects on value co-creation 
practices have been realized. Likewise, it would be of interest to learn how the requirements 
due to employing advanced analytics has impacted the healthcare ecosystem actors, their 
relationships and work culture, as well as how the change management in such major shift 
could be facilitated. Moreover, it would be interesting to study how the actors have adapted 
to the affected or new value co-creation practices, for example what went well and what was 
challenging. 
 
To study more especially strategic benefits and business value achieved through advanced 
analytics would also be of interest. In addition, studies on patients’ experiences of 
personalized care and using health benefit analysis, as well as becoming an active actor in 
value co-creation, would be interesting. Likewise, the actual impacts in the population health 
and expected reduction in health inequalities are of interest. 
 
Similar studies in international context would be interesting, too. For example, covering 
selected EU countries, or other geographical areas to compare the maturity of digitalization 
and preparedness for applying advanced analytics in healthcare in various countries.  
 
5.5. Limitations 
 
The HBA development project is in the time of conducting this study in a pilot phase. 
Therefore, the realization of the anticipated impacts in value co-creation practices and 
potential benefits are recommended to be revised after the HBA tool has been in active use 
for several months. Since this study examines the implementation of the HBA tool in Finland 
in specific health centers at a certain point of time, the results are limited to describing only 
the current situation in these health centers. The empirical results of this study may, however, 
guide other Finnish or international healthcare service providers who intend to introduce the 
HBA tool.  
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APPENDIX 1. Examples of results generated with Health Benefit Analysis tool 
The following examples illustrate the results of Health Benefit Analyses for an individual 
patient as a list of net impacts of different interventions (Table 1), health impact of Ivabradin 
(drug) for the same individual patient (Table 2), and an example of health benefit on 
population level (Table 3). 
 
Example 1. 
 
The health benefit analysis for an individual is a tool for making a care plan. Estimating net 
benefits or harms of interventions by allowing the person to determine the importance of each 
outcome could help in shared decision-making when making choices between alternative 
interventions. 
 
 
 
Table 1. Health benefit analysis for an individual. 
 
The health benefit analysis is listing interventions that the person has not yet received, and 
their estimated health impacts. In this example, also an intervention with marginal net benefit 
(colorectal cancer screening) and one with net harm (PSA screening) are shown.  
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Example 2. 
 
The health impact (benefit or harm) of a single outcome of an intervention is calculated by 
multiplying the absolute effect with the importance of the outcome. The net benefit or harm 
of an intervention is the sum of net impact of all its outcomes. 
 
 
Table 2.  Health impact of Ivabradine (drug) for heart failure.  
 
Calculating the health impact of an intervention on the basis of knowledge (green), 
importance of each outcome as determined by the individual (red), and numbers calculated 
from these numbers (yellow). The baseline risk should be estimated individually. The 
following calculations are performed in the table: Absolute effect = relative effect x baseline 
risk. NNT (number needed to treat) = 1/absolute effect. Importance of outcome = severity of 
the outcome x duration of the outcome (expressed in months – the maximum time span in 
the example is 5 years = 60 months). Benefit or harm = absolute effect x importance of 
outcome. Health impact = sum of all values in the benefit or harm column (benefits are 
expressed as positive values, harms as negative values). 
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Example 3. 
 
On the population level, the health benefit analysis helps in allocating resources for the 
provision of interventions that result in the largest health benefit for the population. If data 
on the unit costs of interventions are available, the interventions can be ordered according to 
cost-effectiveness by using net benefit as a measure of effectiveness. 
 
 
 
Table 3. Potential to benefit from various interventions in the population. 
 
An example of health benefit from filling the care gap in a population for three interventions 
in example case of managing a health care budget and have limited resources. Results of 
health benefit analysis provide support with deciding which programs to support: smoking 
cessation counseling for all eligible, statins for all eligible, or total knee arthroplasty for all 
eligible. 
 
(Examples adapted from Kunnamo 2016: 67; Kunnamo & Alper 2016; 18, 22 – 23; Kunnamo 
& Alper 2017: 1 – 4).  
Intervention  PTB 
average in 
the 
population  
Cost of the 
intervention 
for one 
patient  
Cost/PTB 
(cost 
effectiveness)  
Number of 
patients in 
need of 
intervention 
(N)  
Health 
benefit in 
the 
population 
(PTB x N)  
Cost of 
treating all 
patients  
(Cost x N)  
Smoking 
cessation 
counseling  
0.27  500  1851  3000  810  1 500 000  
Statin  0.49  1000  2040  1800  882  1 800 000  
Arthroplasty 
(knee 
osteoarthritis) 
2.4  20 000  8333  200  480  4 000 000  
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APPENDIX 2. Step by step description of health benefit analysis 
1. All data about the patient (from the EHR (electronic health record), PHR (personal health 
record), wearable devices, Kanta eArchive, biobanks) is the starting point in making a care 
plan.  
2. Clinical decision support based on trustworthy guidelines analyzes the data by using 
evidence-based rules, risk calculators and databases (including big data and genomic 
databases). A PICO (Patient group, Intervention, Comparator, Outcome) ontology links 
evidence to the health problems and characteristics of the individual patient.  
3. Clinical decision support identifies care gaps and interventions that could improve health 
outcomes of the patient.  
4. Recommendations are constructed to fill the care gap. If the patient has many health 
problems, individual recommendations from many clinical practice guidelines and care 
pathways will be listed.  
5. Clinical decision support tools that utilize risk calculators, prognostic models, and 
interactive summary of findings tables of research evidence are used to quantify benefits and 
harms individually for the patient, so that the interventions that would benefit the patient 
most are on top. Interactions of interventions (such as drug-drug interactions), and 
concordant and discordant recommendations are taken into account at this stage.  
6. The recommendations are shown to the patient, using decision aids that make the benefits, 
harms, and burdens of interventions easier to understand. The patient chooses which 
interventions he or she is willing to use. The patient defines his or her individual targets 
(together with the professional) according to the principles of the chronic care model.  
7. The interventions that have been chosen to be performed are recorded in the structured 
care plan. Care protocol templates can be used for recording bundles of interventions.  
8. The actions recorded in the care plan have codes that can be analyzed to guide the process 
of care and the provision of care for the whole population.  
9. The patients are offered self-care interventions and tools and on-line health coaching.  
10. Actions needed from health care professionals serve as input to resource planning tools 
that link the actions with the competencies, equipment, rooms, and other resources needed 
for their completion. Bookings can be automated and can also be made by the patient.  
11. The resource planning tools place the actions on the task list and schedule of 
professionals. Tools are provided that make the work easier and faster. The right thing is 
made the easy thing to do.  
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12.  The resource planning tools have access to all care plans of all people in the population. 
In this way the volume of care needed, and the availability of resources is known when the 
care plans are made for individual patients. If overuse of resources threatens, the care plan 
can be modified. When prioritizing actions for individual patients in the population, the 
conclusions from steps 5 and 6 are used as guidance.  
13. The patient and the professional meet face-to-face or virtually.  
14. The professionals record observations and interventions in the structured EHR from 
where they are forwarded to the national eArchive and big data repository.  
15. The patient records his or her health data, symptoms, and functional ability, as well as 
measurements from home monitoring into the PHR from where they are available for analysis 
by CDS.  
16. The data recorded by the professionals, patients, and devices are anonymized and stored 
in a big data repository where they are used for the creation of new knowledge and for 
developing prediction models. The big data repository can also receive data from the patient’s 
environment, and position data can be linked with patients.  
17. CDS uses both individual patient data and big data for determining the patient’s baseline 
risk for events, and making recommendations (”search from history earlier patients that are 
similar to the index patient and see what happened to them”). In a learning health care system 
every single data item (such as a single blood pressure measurement) contributes to 
knowledge. Similarly, every path of the patient can be analyzed for finding shortcuts in the 
care of future patients.  
 
(Adapted form Kunnamo 2016: 65 – 66).  
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APPENDIX 3. Interview structure 
Interviewee 
Title 
Company/Organization 
Date/Duration 
 
1. Describe the Health Benefit Analysis (HBA) tool development project and your 
organization’s and your own role in it. 
2. Why is the HBA tool developed and who are the main target groups? 
3. Which competences or roles you expect are required in healthcare service delivery and 
ecosystem when the HBA tool is in use? 
4. What kind of resources does the HBA tool consist of, such as databases and techniques? 
5. What kind of data and information types the tool uses? 
6. Describe the capabilities of the tool, e.g. in terms of traceability, analytical capability, 
decision support and predictability. What additional features or capabilities you would 
think would be useful in the tool? 
7. How does the use of the HBA tool enhance or change the following practices or way of 
working in healthcare service delivery?  
- Meaningful use of electronic health records practices 
- Evidence-based medicine practices 
- Practices in multidisciplinary teams 
- Clinical resource integration and allocation practices 
- Network collaboration practices 
- Network knowledge creation practices 
- Personalized care practices 
- Other healthcare service delivery practices 
8. How would you describe the benefits of using the HBA tool for healthcare service 
providers through the following benefit dimensions? 
- IT infrastructure benefits 
- Operational benefits 
- Organizational benefits 
- Managerial benefits 
- Strategic benefits 
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9. In your opinion, what are the benefits of using the HBA tool for individual patients? What 
does it require from the patients themselves? 
10. In your opinion, what are the benefits of using the HBA tool for the population, living 
e.g. in the area of a specific health center? 
11. Do you see any specific challenges or barriers regarding the development or usage of the 
HBA tool?  
12. What makes the development and usage of the HBA tool possible? 
13. Do you have anything else in mind regarding the development or usage of the HBA tool? 
14. In your opinion, what is most important to consider in the HBA tool development and 
implementation? 
 
